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Abstract: 
Retaining glycoside hydrolases cleave their substrates through stereochemical retention at the 
anomeric position. Typically, this involves two-step mechanisms using either an enzymatic 
nucleophile via a covalent glycosyl enzyme intermediate, or neighboring group participation 
by a substrate-borne 2-acetamido neighboring group via an oxazoline intermediate; no 
enzymatic mechanism with participation of the sugar 2-hydroxyl has been reported. Here, we 
detail structural, computational and kinetic evidence for neighboring group participation by a 
mannose 2-hydroxyl in glycoside hydrolase family 99 endo-Į-1,2-mannanases. We present a 
series of crystallographic snapshots of key species along the reaction coordinate: a Michaelis 
complex with a tetrasaccharide substrate; complexes with intermediate mimics, a sugar-shaped 
cyclitol ȕ-1,2-aziridine and ȕ-1,2-epoxide; and a product complex. The 1,2-epoxide 
intermediate mimic displayed hydrolytic and transfer reactivity analogous to that expected for 
the 1,2-anhydro sugar intermediate supporting its catalytic equivalence. Quantum 
mechanics/molecular mechanics modelling of the reaction coordinate predicted a reaction 
pathway through a 1,2-anhydro sugar via a transition state in an unprecedented flattened, 
envelope (E3) conformation. Kinetic isotope effects (kcat/KM) for anomeric-2H and anomeric-
13C support an oxocarbenium ion-like transition state and that for C2-18O (1.052 ± 0.006) 
directly implicates nucleophilic participation by the C2-hydroxyl. Collectively, these data 
substantiate this unprecedented and long-imagined enzymatic mechanism. 
  
Introduction 
Glycoside hydrolases (glycosidases) catalyze the transfer of the glycosyl group of glycosides 
to water or another nucleophilic molecule.1 One major group of glycosidases are those that 
cleave their glycoside substrates with a net retention of anomeric configuration. Retaining 
glycosidases typically operate through two-step mechanisms involving a covalent glycosyl 
enzyme intermediate formed from a nucleophilic amino acid residue (Asp, Glu or Tyr) (Fig. 
1a). Alternatively, certain retaining hexosaminidases act through a mechanism involving 
neighboring-group participation by the 2-acetamido (or glycolylamido) group of the substrate. 
 
While there is extensive evidence for neighboring group participation by a 2-acetamido 
group in hexosaminidases, these are the only glycosidases for which neighboring group 
participation is accepted. Interestingly, there is a large body of evidence supporting 
neighboring group participation by a glycoside 2-hydroxyl in the alkaline cleavage of 1,2-trans 
glycosides and glycosyl fluorides and 1,2-anhydro sugars (a 1,2-epoxide) as intermediates. 
This data includes the well-known differences in the rate of alkaline hydrolysis of 1,2-cis- 
versus 1,2-trans-glycosides, the reduced rate of alkaline hydrolysis of otherwise identical 2-
alkylated 1,2-trans-glycosides,2 and retention of anomeric stereochemistry in the alkaline 
methanolysis of 1,2-trans-glycosyl fluorides whereas 2-alkylated 1,2-trans-glycosyl fluorides 
react with inversion.3 Kinetic isotope effects for the alkaline hydrolysis of 4-nitrophenyl D-D-
mannopyranoside have given direct evidence for neighboring-group participation by a C2-
oxyanion.4 Neighboring group participation by a 2-hydroxyl has also been proposed for other 
glycoside hydrolases,5-6 but none have withstood cursory, let alone detailed, mechanistic 
scrutiny.7-9 
 Figure 1. Proposed mechanisms for a retaining glycoside hydrolase applied to a GH99 
endo-D-1,2-mannanase. a, Classical Koshland mechanism involving an enzymatic 
nucleophile and a glycosyl enzyme intermediate. Residue numbering is for BtGH99. b, 
Alternative mechanism involving neighboring group participation by the 2-hydroxy group 
and a 1,2-anhydro sugar intermediate. c, Structures of ligands used in this study.  
 
Glycoside hydrolases of CAZY (see www.cazy.org; www.cazypedia.org)10-11 family 
99 are endo-acting retaining glycosidases that cleave D-mannosidic linkages within D-mannans 
in the yeast cell wall (endo-D-1,2-mannanases)12 and mammalian glucosylated high-mannose 
N-glycans (endo-D-1,2-mannosidases).13-15 These enzymes have important roles in fungal cell 
wall degradation in the human gut microbiota16 as well as processing of glucosylated 
intermediates in N-glycan biosynthesis,17 respectively. For both types of enzyme, the minimum 
substrate for these enzymes is a disaccharide in which the reactive, ±1 mannosyl residue is 
modified at the 3-position with either an D-mannosyl or D-glucosyl residue. The first X-ray 
structures of members of GH family 99, endo-D-1,2-mannanases from Bacteroides 
thetaiotaomicron and Bacteroides xylanisolvens, BtGH99 and BxGH99, respectively, provided 
hints of an atypical mechanism.18 These bacterial representatives act on both D-glucosyl- and 
D-mannosyl-1,3-D-mannosides (with around 10-fold preference for the latter), and structural 
studies using substrate-like ligands were applied to identify the enzymatic catalytic machinery. 
However, 3-dimensional structures of wild-type BtGH99 in complex with the isofagomine-
derived inhibitors GlcIFG18 and ManIFG,12 and a disabled non-catalytic mutant in complex 
with a substrate12 failed to identify a likely enzymatic nucleophile appropriately situated near 
the fissile anomeric bond. Enticingly, complexes with deoxymannojirimycin-derived inhibitors 
GlcDMJ18 and Man-2-amino-DMJ,19 noeuromycin-derived inhibitors GlcNOE18 and 
ManNOE,20 and of the E333Q mutant with substrate,12 highlighted an interaction between a 
carboxylate residue and the 2-hydroxyl of the ±1 mannosyl residue. Collectively, these data 
were suggestive of an alternative mechanism involving a 1,2-anhydro sugar intermediate (Fig. 
1b); however, no studies have provided direct evidence for participation of O2 or insight into 
the proposed epoxide intermediate.  
 Here, we present an analysis of the reaction mechanism of GH99 endo-D-1,2-
mannanases. X-ray data of molecular probes, designed to mimic species along the reaction 
coordinate, provides a snapshot of key catalytic states. These results are extended by applying 
quantum mechanics/molecular mechanics (QM/MM) methods to study the enzyme-catalyzed 
reaction, giving computational support for the formation of a 1,2-anhydro sugar intermediate. 
We also show that a cyclitol epoxide mimic of the 1,2-anhydro sugar exhibits reactivity that is 
consistent with the expected reactivity of this intermediate. Finally, we measure kinetic isotope 
effects that provide direct experimental support for neighboring-group participation by the 
substrate 2-hydroxy group in Bt and BxGH99.  
  
Results 
Structures of the 'Michaelis' and product complexes of BxGH99 
As a first step in the mechanistic dissection of GH99 enzymes, and to provide structural data 
for computational approaches to study the reaction coordinate, we sought to define, at near 
atomic resolution, the two ends of the reaction coordinate. We thus determined substrate 
('Michaelis') and product complexes of BxGH99. A catalytically-inactive variant, E333Q, was 
used to obtain a complex with the substrate Man4OMe (representing a fragment of the yeast 
mannan that is the substrate for this bacterial enzyme),12 at a resolution of 1.07 Å, Fig. 2a (for 
X-ray data collection and refinement statistics see Table S1). The intact tetrasaccharide 
occupies the ±2 to +2 subsites,21 spanning the active site. 
  
  
Figure 2. X-ray snapshots along the BxGH99 reaction coordinate. X-ray structures of a, 
BxGH99-(4ERXQGWRĮ0DQ-1,3-Į0DQ-1,2-Į0DQ-1,2-Į0DQ-OMe [(Man)4OMe]; b, 
BxGH99-(4ERXQGWRĮ-1,3-PDQQRELRVHDQGĮ-1,2-mannobiose. Mutated active site 
residue in italics. c, Proposed reaction coordinate of the GH99 catalyzed reaction (X = 
Į0DQd, X-ray structures showing the ±2/±1 subsites for the Michaelis complex: BxGH99-
E333Q with (Man)4OMe; intermediate complex: wildtype with cyclohexane E-1,2-aziridine 
1DQGSURGXFWFRPSOH[Į-1,3-PDQQRELRVHDQGĮ-1,2-mannobiose with wildtype. 2mFo-Fc 
weighted electron density maps contoured at 0.8 e-/Å3 in all cases. 
 Within the Michaelis complex, the ±1 mannoside residue adopts a 4C1 conformation 
that is slightly distorted towards 2E; this distortion can be confidently assigned at the atomic 
resolution of the data. There is no major protein conformational change (indeed, none has been 
seen in any GH99 structure) and, as seen in previous disaccharide and inhibitor complexes, no 
candidate enzymatic nucleophile is located near the reactive anomeric C1 carbon. Tyr252 is 
approx. 4 Å away from C1 in BxGH99 and mutagenesis of the equivalent residue in human 
endo-D-mannosidase (39% sequence identity to BxGH99) gave a mutant enzyme that 
maintained its ability to perform transglycosylation, excluding the possibility that this residue 
provides nucleophilic catalysis.22 Of note is the interaction, 2.8 Å, between the NH2 of the 
introduced Gln333 with the O2 of the ±1 subsite mannoside. The natural Glu at this position is 
proposed to act as catalytic base for the deprotonation of O2 during the formation of the 1,2-
anhydro sugar intermediate (Fig. 1b). The Michaelis complex shows that this residue is ideally 
placed, consistent with the complete loss of activity when Glu333 is substituted by Gln.18 
The final enzyme-bound state of the reaction coordinate was determined through 
studies of product complexes. We solved ternary complexes of wildtype and E333Q variant 
BxGH99 enzymes with the two products of hydrolysis: Į-1,3-PDQQRELRVH DQG Į-1,2-
mannobiose, at 1.08 Å and 1.65 Å resolution UHVSHFWLYHO\ ,Q ERWK FRPSOH[HV Į-1,3-
mannobiose bound in the ±2, ±1 subsites, DQGĮ-1,2-mannobiose bound in the +1, +2 subsites 
(Fig. 2b, Fig. S1). Comparison of the Michaelis and product complexes reveals that in the latter 
complex, the ±1 sugar is in a relaxed 4C1 conformation, which is consistent with the lack of a 
covalent bond connecting the ±2/±1 and +1/+2 sugars, and the +1 mannose residue is shifted, 
such that it makes different hydrogen bonds to the protein. Thus, in the substrate complex the 
+1 mannose O3 hydrogen bonds to E336 O1, whereas in the product complex O3 is hydrogen 
bonded with Y289 and a water molecule resides where O3 sat in the substrate. Similarly, in the 
substrate complex the +1 mannose O4 hydrogen bonds with water whereas in the product 
complex hydrogen bonds with the Y289 oxygen (see Fig. S2). 
Both the 'Michaelis' and product complexes are thus consistent with a reaction 
mechanism involving neighboring-group participation by the substrate 2-hydroxy group, 
activated through deprotonation by Glu333 and with Glu336 acting as the catalytic acid for 
leaving group departure. Given this enticing structural support for this mechanism, we next 
sought to dissect the reaction coordinate using a computational approach.  
 
QM/MM metadynamics simulations of the endo-D-1,2-mannanase-catalyzed reaction 
To probe the potential neighboring-group participation by the substrate 2-hydroxy group, we 
modelled the reaction mechanism of the endo-D-1,2-mannanase-catalyzed reaction using 
classical molecular dynamics (MD) and QM/MM metadynamics simulations (see 
Supplementary Methods).23-24 This approach accounts for the room temperature motion of 
the enzyme during the reaction while providing QM (DFT) accuracy for the description of the 
active site atoms. It has been used with success to model reaction mechanisms in a wide range 
of carbohydrate-active enzymes,25 including Golgi Į-mannosidase II.26 Two collective 
variables (CVs) were used to define the reaction coordinate starting with the Michaelis 
complex, described above. These variables were chosen as to include the main bonds that are 
to be made/broken during the reaction (Figure 2c). The first collective variable (CV1, 
representing nucleophilic attack) was defined as the distance difference between C1-O1 and 
O2-C1. The second collective variable (CV2, glycosidic bond protonation) was defined as the 
distance between O1-HE336 and HE336-OE336. 
The free energy landscape reconstructed from the simulation (Fig. 3a) shows that the 
Michaelis complex evolves to the product via a 1,2-anhydro sugar intermediate. An energy 
barrier of ǻ*Á §5 kcal/mol between the Michaelis complex (MC) and the transition state (TS) 
leads to the formation of a 1,2-anhydro sugar (EPO; local minimum on the right-hand-side). 
The computed free energy barrier is in good agreement with the available kinetic data;16 the 
reaction is therefore both feasible and favored. The two minima located in the reactants region 
0&DQG0&¶correspond to alternative arrangements of the Michaelis complex in which the 
O-H bond of the acid/base residue E336 twists to point either towards the glycosidic oxygen 
or the +1 saccharide. The calculated TS is dissociative, with the glycosidic bond elongated 
(C1±O1 = 1.88 ± 0.06 Å; Fig. 3b and Table S2) and the O2 atom at an early stage of attack on 
the anomeric carbon (C1±O2 = 2.29 ± 0.06 Å), causing weakening of the C2±O2 bond. 
Analysis of the structures along the reaction coordinate (Fig. 3c,d) reveals distortion of the ±1 
mannosyl ring during the reaction, following a 2E/2H3 ĺ>E3]Á ĺ4E/4H5 itinerary during the 
first half of the reaction, which can be considered an 'electrophilic migration' of C1 from the 
leaving group oxygen in the Michaelis complex, to the nucleophilic O2 in the EPO complex 
(Fig. S3). The conformation of the MC (2E/2H3) is similar to the one obtained from the X-ray 
structure (between 4C1 and 2E; see Fig. S4), with only slight differences that can be attributed 
to the E333Q mutation in the X-ray structure altering the nature of the interaction of this residue 
with the substrate 2-OH. The conformation of the ±1 mannosyl residue at the TS (E3) achieves 
planarity of C2±C1±O±C5, as required for an oxocarbenium-ion-like transition state.1 Finally, 
the calculated 1,2-anhydro sugar intermediate is in a 4E/4H5 conformation, in agreement with 
the X-ray structure of the wildtype enzyme in complex with cyclohexane E-1,2-aziridine (vide 
infra).  
 Figure 3. QM/MM metadynamics modelling of the BxGH99 endo-D-1,2-mannanase 
catalyzed reaction. a, Free energy landscape (FEL) of the enzymatic reaction with respect to 
the two collective variables described in the text. Contour lines are at 0.5 kcal/mol. b, Evolution 
of relevant distances along the minimum free energy pathway (reaction coordinate). Averages 
over all configurations sampled for each point on the pathway are considered. Error bars 
correspond to standard deviations. c, &RQIRUPDWLRQDO LWLQHUDU\RIWKHĮ-mannoside at the ±1 
subsite along the reaction coordinate projected into 6WRGGDUW¶V GLDJUDP. c, Representative 
snapshots of the main states along the reaction coordinate (MC, MC', Michaelis complexes; 
TS, transition state; PT, proton transfer; EPO, EPO', 1,2-anhydro sugar. 
 
To explore other possible mechanisms, we performed simulations with different 
collective variables. In particular, we quantified whether the canonical Koshland-type 
mechanism is a viable alternative mechanism for BxGH99.  To do so, an additional 
metadynamics simulation was performed in which the O2 atom was not included in the CV set, 
thereby excluding any bias towards the epoxide formation. Specifically, we considered 
common CVs used to describe a classical Koshland double displacement reaction (i.e. 
considering the OE333-C1 and C1-O1 distances as CV1 with the same CV2 as in the previous 
simulation).27 The results, shown in the Supporting Information, reveal that even in this case, 
a double displacement reaction is not favorable; instead E333 acts as a base to abstract a proton 
from the 2-OH, leading to the same epoxide intermediate (Fig. S5). Altogether, our simulations 
provide computational support for a neighboring-group participation mechanism for BxGH99 
endo-D-1,2-mannanase. 
 
Structures and reactivity of intermediate-mimicking complexes 
To study the interactions and reactivity of the intermediate, we designed and synthesized 
compounds that mimic the GH99 Glc/Man-Į-1,3-OLQNHGȕ-1,2-anhydrosugar intermediate. To 
improve their chemical stability, we replaced the endocyclic oxygen with methylene (CH2), as 
previous work showed that the affinity of a glycal inhibitor was similar to that of the 
corresponding cyclohexene.20 Thus, we synthesized cyclohexane-ȕ-1,2-epoxide 1 and 
cyclohexane-ȕ-1,2-aziridine 3 (Fig. 1c). To demonstrate stereospecificity, and to control for 
potential promiscuous reactivity of epoxides, we also synthesized the D-isomers: cyclohexane-
D-1,2-epoxide 2 and cyclohexane-D-1,2-aziridine 4.28 
As reactivity of an intermediate mimic can provide strong evidence for mechanism, the 
ability of BtGH99, BxGH99 wild-type, E333Q and E336Q to catalyze reactions of these 
compounds was studied by mass spectrometry. The only enzyme-catalyzed reaction observed 
ZDVIRUWKHȕ-1,2-epoxide 1, which was converted to an M+18 species (Fig. 4, Fig. S6); the D-
1,2-epoxide 2 and both D- DQGȕ-1,2-aziridines, 3 and 4 were inert (see Fig. S7 for data for 
other compounds). The lack of reactivity of D-1,2-epoxide 2, which stands in contrast to the 
reactivity observed for ȕ-1,2-epoxide 1, is consistent with stereochemical specificity of GH99 
enzymes, and provides evidence that there is not a nucleophilic enzymatic residue situated 
'above' the sugar ring. The rate of formation of the M+18 species was linear as a function of 
time and was proportional to enzyme concentration. Using mass spectrometry the rates of 
product formation were 0.090 s-1 for BtGH99 and 0.047 s-1 for BxGH99, in concordance with 
data showing GlcManF is turned over more slowly by BxGH99 than BtGH99.18 1H NMR 
spectroscopy of the product of the reaction revealed it to be a vicinal diol with an D-
configuration 5 matching that of the product of the endomannanase reaction (Supporting 
methods). Thus, the cyclohexane E-1,2-epoxide exhibits reactivity expected for a 1,2-anhydro 
sugar intermediate, but with a rate of turnover approximately 1/30th of that of Glc-Man 
fluoride18 at the same concentration, a result consistent with a reduced reactivity arising from 
the reduced charge-stabilization at the transition state because of the absence of an endocyclic 
oxygen. Notably, the D-1,2-epoxide 2 did not react with the GH99 enzyme to yield a covalently 
labelled enzyme, as might be expected if GH99 enzymes used an enzymatic nucleophile based 
on similar precedents with variants of cyclophellitol epoxide and its aziridine.29 
  
  
Figure 4. Structure and reactivity of cyclohexane E-1,2-epoxide. a, Enzyme-catalyzed 
reaction of cyclohexane E-1,2-epoxide. b, Monitoring of enzyme-catalyzed reaction of 
cyclohexane E-1,2-epoxide by mass spectrometry with wildtype and E333Q and E336Q 
mutants. X-ray structures of c, Cyclohexane E-1,2-epoxide with BxGH99 E333Q mutant 
(2mFo-DFc at 0.8 e-/Å3); d, Hydrolysis product trans-1,2-diol with wildtype (2mFo-DFc at 
0.5 e-/Å3) and with e, E336Q mutant (2mFo-DFc at 0.5 e-/Å3). 
 
The stability of the ȕ-1,2-aziridine 3 to enzyme action (XQOLNHȕ-epoxide 1) enabled the 
measurement of a binding constant (KD) of 17.7 ± ȝ0 for BtGH99 using NMR, as described 
previously20 (Fig. S8). The 3-D structure of aziridine 3 bound to GH99 provides the first 
structural insight into an intermediate-mimicking complex (Fig. 2d). The complex of the 
wildtype enzyme with WKHȕ-1,2-aziridine was obtained at 1.25 Å resolution and subsequently 
at 1.07 Å for a ternary complex including D-1,2-mannobiose. The ±1 pseudosugar is observed 
in a 4E conformation, as predicted by QM/MM calculations, and consistent with the proposed 
2E/2H3 ĺ>E3]Á ĺ 4E/4H5 conformational itinerary. Within both structures the aziridine N±
(2İGLVWDQFHLV Å, supportive of a role for E333 as acid/base residue.  
 
The greater reactivity of the epoxide species, and its regioselectivity for enzyme-
catalyzed ring opening, matches that expected for the putative 1,2-anhydro sugar intermediate 
and prompted efforts to obtain an epoxide co-complex with BxGH99. Crystal structures of the 
cyclohexane ȕ-1,2-epoxide 1 were subsequently obtained with the wildtype and both the 
E333Q and E336Q mutants, at resolutions of 1.28 Å, 1.12 Å and 1.34 Å, respectively (Fig. 4c). 
Consistent with the proposed mechanism in which E333 is the base required for epoxide 
opening, the epoxide remained intact for the E333Q mutant, and was opened to the trans-1,2-
diol 5 with both wildtype and the E336Q mutant. As with the aziridine, the epoxide binds in a 
4E conformation, matching the QM/MM calculations. The trans-diaxially-opened 
cyclohexanediol was Į-configured and in a product-mimicking 4C1 conformation. These results 
FRQILUPWKDWWKHȕ-1,2-HSR[LGHULQJLVRSHQHGE\*+\LHOGLQJDQĮ-configured product, and 
that the E333 residue is required for this activity. For a direct comparison of the structures of 
complexes with the intermediate mimics, see Fig. S9. 
 
Human endo-D-1,2-mannosidase catalyses glycosylatLRQ RI Į-1,2-mannobiose with 
retention of stereochemistry using Glc-Man fluoride as donor to yield GlcManManMan, and it 
is proposed that this reaction proceeds through a 1,2-anhydro sugar intermediate.22 Incubation 
of BtGH99 and BxGH99 wildtype enzymes with WKHȕ-epoxide 1 DQGĮ-1,2-mannobiose yielded 
a product with mass spectrometric data consistent with a Glc-carbamannose-Man2 
tetrasaccharide (m/z of 883.4 assigned to the permethylated M+Na species detected using 
MALDI-MS, see Fig. S10 and Supporting Methods). The proposed alkylation reaction 
mechanism is shown in Fig. S11. 
 
Kinetic isotope effect analysis of substrate cleavage 
The foregoing structural and reactivity data with substrate, product and putative intermediate 
mimics and the accompanying computational data are collectively consistent with the proposed 
neighboring group participation by O2 but do not directly demonstrate the involvement of this 
residue in the enzymatic mechanism. Kinetic isotope effects (KIEs) are a powerful method to 
directly study transition state structure as they allow differences in rate of isotope-substituted 
substrates to report on hybridization, bond order and geometry changes between the ground 
and the transition states. Unlike substrate variation studies, KIE studies utilize isotopologues 
that vary only in the number of neutrons at specific sites, and thus constitute a minimal 
perturbation to the substrate. We recently reported KIEs at six sites (C1, O1, H1, and C2, O2, 
and H2) for the alkaline solvolysis of PNPMan, which proceeds through a C2-oxyanion en 
route to a 1,2-anhydro sugar.4 Among the most characteristic KIEs were a strikingly large 
16O/18O KIE for O2 of 1.044 ± 0.006, 12C/13C KIEs for C1 of 1.026, and 1H/2H KIE for H1 of 
1.112 (Fig. 5b). These data are supportive of nucleophile participation by an O2 oxyanion, 
rate-limiting C1±OLG bond cleavage, and an exploded transition state arising from the late 
build-up in strain of the epoxide of the intermediate. These KIEs represent benchmark data 
against which to compare KIE data at the equivalent sites for enzymatic cleavage, noting that 
alkaline solvolysis is a specific base-catalyzed process whereas the enzymatic process is likely 
to involve both general-acid and general-base catalysis. 
  
a 
 
site of KIE  
measurement 
'light' 
substrates 
'heavy' 
substrates 
H1 (1-13C) (1-2H,1-13C) 
O2 (2-13C) (2-13C,2-18O) 
C1 (2-13C) (1,2-13C2) 
   
b  Experimental KIEs 
 
position BtGH99 catalyzed 
(this work) 
base promoted hydrolysis 
of PNPMan (Ref.4) 
 
1-2H 1.123 ± 0.012 1.112 ± 0.004 
 
1-13C 1.030 ± 0.005 1.026 ± 0.006 
 
2-18O 1.052 ± 0.006 1.044 ± 0.006 
 
   
c distance (Å) TS structure for BxGH99 
hydrolysis of (Man)4OMe 
TS structure for PNPMan 
hydrolysis (Ref. 4) 
 
&«2 1.9 2.3 
 
&«2 2.3 2.0 
 
2«2 2.7 2.7 
 
Figure 5. Substrate structures and kinetic isotope effect measurements. a, Structure of 
substrate and table of isotopologues required for measurement of 2H-, 13C- and 18O-KIEs. b, 
Table of KIEs (± standard error) for the BtGH99 catalyzed hydrolysis of the tetrasaccharide 
substrate; and published KIEs (± standard error) for the base-promoted hydrolysis of 4-
nitrophenyl D-D-mannopyranoside (PNPMan). c, Calculated critical interatomic distances for 
the calculated transition states for BtGH99 catalyzed hydrolysis of the tetrasaccharide 
substrate; and published KIEs for the base-promoted hydrolysis of PNPMan. 
 
Chan et al. reported the development of a highly sensitive competitive NMR method that 
allows the high precision measurement of KIEs on milligram quantity mixtures of light and 
heavy isotopologues each possessing an NMR active probe nucleus (typically 13C) that reported 
on an adjacent site labelled with light and heavy isotopes.30 An NMR spectrometer is used to 
measure competitive KIEs for the second-order rate constant (kcat/KM) by monitoring reaction 
mixtures of isotopologue substrates. Owing to redundancies, measurement of KIEs using this 
technique at the C1, H1 and O2 positions requires just 4 isotopologues labelled at one or two 
positions. Prior work showed that simple aryl disaccharides are poor substrates for Bt and 
BxGH99.12 Thus, we elected to synthesize the tetrasaccharide (Man)4OMe as a preferred 
substrate. A reliable 24-step synthesis (13 of which were on isotope-labelled intermediates) 
was developed and applied for the synthesis of five isotopologues, plus the parent unlabelled 
tetrasaccharide. Despite its length, the efficiency of this approach allowed conversion of less 
than 100 mg of isotopically-labelled D-mannoses to sufficient amounts of tetrasaccharide for 
measurement of KIEs using the competitive NMR technique. 
KIE measurements were performed by acquisition of quantitative 13C NMR spectra of the 
BtGH99-catalyzed hydrolysis of mixtures of approximately 1 mg each of the 13C-labelled pair 
of compounds possessing light or heavy isotopes at the adjacent position (Fig. 5a). Due to the 
presence of a minor 13C-labelled impurity, which was impervious to GH99 catalysis, the 
spectrum for the reaction at completion was subtracted from the spectra acquired earlier, on the 
same sample, at varying degrees of completion. Following processing and normalization of 
data, KIE effects were calculated (Table S3, Fig. S12, S13, S14). The KIE values reveal the 
1H/2H KIE for H1 of 1.123, 12C/13C KIEs for C1 of 1.030, and 16O/18O KIE for O2 of 1.052 
(Fig. 5b). While these KIE measurements are less precise than we would have wished due to 
the unknown 13C-labelled impurity they show that there are significant zero-point energy 
changes at C1 and O2 and these KIE values are clearly consistent with nucleophilic 
participation by O2 that leads to formation of an epoxide intermediate. 
Strikingly, the enzymatic KIE values are essentially identical to that measured for the base-
promoted (non-enzymatic) reaction, providing support for a similar transition state structure 
and reaction mechanism. The anomeric 13C-KIE of 1.030 is in the range associated with SN2 
reactions on glycosides that proceed through 'exploded' dissociative transition states. The D-
secondary deuterium KIE for glycosidic bond fission originates mainly from changes in 
bending vibrations as the anomeric carbon undergoes rehybridization from sp3 to sp2 at the 
transition state. The 1H/2H KIE for H1 of 1.123 is smaller than for reactions that proceed 
through bona fide glycopyranosylium ions, consistent with an exploded SN2-like transition 
state, as also predicted by the QM/MM simulations. The non-unity 16O/18O KIE of 1.052 for 
O2 indicates TS involvement of O2 as a nucleophile. The magnitude of this KIE reflects 
vibrational frequency changes between the ground state and the transition state leading to 
epoxide formation. For both the enzyme-catalyzed and base-promoted reactions the formation 
of the three-membered epoxide ring involves the build-up of significant angle strain (~27 kcal 
mol-1)31 and this results in weakening of the C2-oxygen bond.  
At first glance there appears to be a difference between the calculated GH99 TS structure, 
where epoxide formation occurs after traversal of the TS, and the magnitude of the heavy atom 
KIEs, which implicate significant motion of the C2-oxygen atom as well as a weakening of the 
O2-H bond. However, we note that the free energy profile in the vicinity of the transition state 
(Fig. 3a) is relatively flat and the reaction coordinate includes a shortening of the C1±O2 
distance (Fig. 3b), which is associated with the bending C1±C2±O2 bending vibration, as well 
as a tightening of the O333 to O2 distance, which results in a significant shortening of the 
distance between H2 and the general-base glutamate, a motion that will also result in zero point 
vibrational changes at the labelled O2 site.  
Comparison of the structures calculated for the TS of the enzyme-catalyzed process using 
QM/MM methods (vide supra) and that calculated using ab initio methods, calibrated with the 
KIE measurements, for the hydroxide-promoted hydrolysis of PNPMan4 provide insights into 
the structure and timing of the respective transition states (Fig. 5c). Qualitatively the data (Fig. 
5c; sum of O2«C1 and C1«O1 distances) suggests similar nucleophile to leaving group 
distances at the two respective TSs, with that for the specific base-promoted oxyanion being 
later, and slightly looser, than that for the GH99 endo-mannosidase-catalyzed reaction. We 
conclude that each of/all of the KIE, computational, and structural studies are consistent this 
enzyme-catalyzed reaction forming an obligatory epoxide intermediate, and that both theory 
and experiment (KIE) entail similar, synchronized, heavy atom motions at the TS that are 
coupled to proton transfer events. 
Discussion 
Enzyme-catalyzed hydrolytic cleavage of the glycosidic bond can occur through a 
spectrum of mechanisms that are unified by oxocarbenium ion like transition states.1 Reactions 
that proceed with retention of configuration involve two-step reaction with either participation 
by an enzymic nucleophile (classical retaining glycosidases) or one borne on the substrate 
(neighboring group participation glycosidases). The case for neighboring group participation 
is convincing for various 2-acetamido-hexosaminidases, where the substrate 2-acetamido 
group acts as a nucleophile assisting departure of the leaving group and formation of an 
oxazoline (or oxazolinium ion) intermediate,32 which is hydrolyzed in the second step.33 Over 
40 years ago, Wallenfels proposed the biological equivalent of this reaction for LacZ E-
galactosidase involving nucleophilic participation by a pyranoside 2-hydroxy group to form a 
1,2-anhydro sugar (or 1,2-epoxide) intermediate;34 subsequently this enzyme was shown to 
utilize a standard retaining mechanism with an enzymatic nucleophile.7 The present work 
provides a body of evidence in support of a neighboring group participation mechanism for 
GH99 involving nucleophilic participation by the 2-hydroxyl group and formation of a 1,2-
anhydro sugar intermediate, a mechanism proposed for GH family 99 endo-D-1,2-
mannosidases/mannanases18 and recently invoked for D-L-rhamnosidases of GH family 145.35 
The structures presented here collectively define a series of snapshots along the reaction 
coordinate of stable molecules that mimic the substrate, intermediate or product. Comparison 
of the start and end structures reveals that the key change in these complexes is the shift in the 
position of the leaving group (O2 of the +1 mannose) as the covalent bond to C1 is cleaved. 
Computational studies suggest that the conformation of the ±1 sugar in the Michaelis complex 
is perturbed by the very action of making an inactive mutant for X-ray crystallographic study 
and predicts a 2E/2H3 conformation. This conformation in the Michaelis complex is unusual for 
mannosidases, which in all other cases adopt distorted OS2, 1S5, 3S1 or 1C4 conformations that 
alleviate the steric interaction between the 2-OH and the incoming nucleophile, providing an 
unfettered nucleophilic trajectory.36 Notably, in the Michaelis complexes, the -1 subsite sugar 
adopts a 2E/2H3 conformation in which the 2-OH sits in between the E333 residue and the 
anomeric carbon, preventing direct nucleophilic attack at C1, and clearly an alternative strategy 
must be employed by GH99 enzymes to catalyze glycosidic bond cleavage.   
The X-ray structure of the Michaelis complex reveals that 2E/2H3 conformation of the 
±1 mannosyl residue positions O2 in a near-axial orientation, where it is poised to act as an 
internal nucleophile to displace the anomeric group. Our QM/MM metadynamics simulations 
show that this leads to a reaction involving nucleophilic attack by O2 on the anomeric carbon, 
forming a 1,2-anhydro sugar intermediate and exclude the classical Koshland double-
displacement mechanism involving an enzymatic nucleophile.  As mimics of the highly 
reactive 1,2-anhydro sugar intermediate, we explored more stable cyclohexane analogues: a E-
1,2-epoxide 1 and a E-1,2-aziridine 3. The E-1,2-aziridine 3 proved sufficiently stable to allow 
acquisition of a complex with BxGH99 (and with the E-1,2-epoxide for a catalytically disabled 
mutant), providing insight into the conformation of a 1,2-anhydro sugar mimic. Both 
complexes gave evidence for the 1,2-anhydro sugar intermediate binding in a 4E conformation, 
as predicted computationally, and showed the proposed catalytic machinery E333 and E336 
positioned appropriately to assist nucleophilic attack by water and provide general acid 
catalysis to open the ring.  
The cyclohexane E- and D-1,2-epoxides 1 and 2 exhibit reactivity that suggests that 
only the former acts as a bona fide mimic of the proposed 1,2-anhydro sugar intermediate. In 
particular, only 1 was a substrate for BtGH99, and underwent regioselective hydrolysis as the 
position equivalent to the anomeric position, to give a 1,2-trans product 5. The reactivity profile 
of E-1,2-epoxide 1 extends to reaction with 1,2-D-mannobiose, which yielded a 
pseudotetrasaccharide, a reaction analogous to the transglycosylation reaction of HsGH99 
using GlcManF with 1,2-D-mannobiose,22 recapitulating the reactivity invoked for the 1,2-
anhydrosugar intermediate.  
Kinetic isotope effects are considered the gold standard for experimental investigations 
of transition state structure. Using a highly sensitive competitive NMR method we measured 
Į-secondary KIEs for 1H/2H for H1 of 1.123 ± 0.012 and for 12C/13C of 1.030 ± 0.005, and a 
16O/18O KIE for O2 of 1.052 ± 7KHĮ-secondary deuterium and primary anomeric 13C-
KIEs are consistent with that expected for a reaction center undergoing sp3 ĺ sp2 
rehybridization at the TS such as that which occurs in an exploded SN2-type reaction. In 
addition, the 16O/18O KIE indicates a primary KIE associated with O2 acting as a nucleophile 
at the experimentally observed TS. These KIEs are essentially identical to benchmark KIEs 
determined for the hydroxide-promoted hydrolysis of 4-nitrophenyl D-mannoside4 (although 
are consistent with an earlier, looser transition state) and provide direct evidence for 
neighboring group participation by BxGH99. 
 
Conclusions 
Collectively the 3-D structures, QM/MM calculations, KIE measurements, and the reactivity 
of cyclohexane epoxide intermediate mimics provide experimental evidence that GH99 
enzymes achieve substitution with retention of stereochemistry through a neighboring group 
participation mechanism by O2 involving general base-assistance by E333 and leading to a 
1,2-anhydro sugar intermediate, via a TS with oxocarbenium ion character.  3-D structures and 
QM/MM calculations are consistent with the enzyme achieving this outcome through a 
conformational itinerary along the reaction coordinate of 2H3 ĺ >E3] Á ĺ 4E. This 
conformational pathway is distinct from that used by all other characterized mannosidases as 
it involves only minor distortion of the ±1 sugar residue at the Michaelis complex, whereas 
pathways involving 3H4 and B2,5 transition state conformations require substantial distortion to 
DOOHYLDWHQXFOHRSKLOH«2LQWHUDFWLRQVThis work provides strong evidence for the existence 
of a 1,2-anhydro sugar mechanism in biological catalysis that is broadly equivalent to the 1,2-
anhydro sugars that have long been implicated as intermediates in the base-promoted 
hydrolysis of trans-1,2-glycosides. 
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Synopsis 
Mannosidases of glycoside hydrolase family 99 use a neighboring group participation 
mechanism involving the substrate 2-hydroxyl. 
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An epoxide intermediate in glycosidase catalysis 
Table S1 | X-ray data collection and refinement statistics. 
 
 E333Q 
'Michaelis' 
complex 
:7ȕ-1,2-
aziridine 
:7ȕ-1,2-
aziridine + 
Į-1,2-
mannobiose 
E333Q + ȕ-
1,2-epoxide 
WT + 
cyclohexane-
diol 
E336Q + 
cyclohexane-
diol 
WT product 
complex 
E333Q 
product 
complex 
Data collection         
Beamline I02 I04-1 I02 I04 I04 I04 I04-1 I04-1 
Space group I4 I4 I4 I4 I4 I4 I4 I4 
Cell dimensions         
    a, b, c (Å) 107.9, 107.9, 
67.6 
108.5, 108.5, 
68.0 
108.6, 108.6, 
67.6 
108.2, 108.2, 
67.4 
108.3, 108.3, 
67.5 
107.6, 107.6, 
67.5 
108.9, 108.9, 
68.5 
108.7, 108.7, 
68.8 
    ĮȕȖq)  90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å)* 57.30-1.07 
(1.09-1.07) 
39.49-1.25 
(1.27-1.25) 
57.42-1.04 
(1.06-1.04) 
76.53-1.12 
(1.14-1.12) 
57.25-1.28 
(1.30-1.28) 
57.17-1.34 
(1.36-1.34) 
58.00-1.08 
(1.10-1.08) 
76.83-1.65 
(1.68-1.65) 
Rmerge 0.061 
(1.531) 
0.059 
(1.664) 
0.075 
(1.346) 
0.063 
(1.387) 
0.066 
(1.445) 
0.069 
(1.278) 
0.059 
(1.455) 
0.084 
(1.014) 
Rpim 0.026 
(0.705) 
0.022 
(0.643) 
0.030 
(0.601) 
0.027 
(0.634) 
0.028 
(0.650) 
0.029 
(0.544) 
0.025 
(0.710) 
0.047 
(0.578) 
CC(1/2) 0.997 
(0.398) 
0.998 
(0.462) 
0.993 
(0.455) 
0.999 
(0.450) 
0.999 
(0.439) 
0.999 
(0.563) 
0.999 
(0.407) 
0.995 
(0.406) 
I ıI 10.6 (1.0) 17.4 (1.3) 9.5 (0.8) 9.8 (1.1) 10.7 (1.2) 10.6 (1.3) 10.1 (1.0) 8.2 (1.1) 
Completeness 
(%) 
100.0 (99.3) 99.4 (100.0) 98.8 (80.4) 100.0 (99.2) 100.0 (99.9) 99.9 (99.5) 99.9 (99.2) 99.6 (99.8) 
Redundancy 6.3 (5.5) 8.2 (7.6) 7.5 (5.5) 6.4 (5.7) 6.4 (5.9) 6.5 (6.3) 6.3 (5.1) 4.0 (4.1) 
         
Refinement         
Resolution (Å)  76.28-1.07 76.69-1.25 76.82-1.04 76.53-1.12 76.56-1.28 76.10-1.34 77.03-1.08 76.83-1.65 
No. reflections all 
/ free 
170019 / 
8420 
108087 / 
5400 
185423 / 
9152 
149020 / 
7398 
100095 / 
4977 
86250 / 4416 170757 / 
8460 
47947 / 2376 
Rwork / Rfree 0.120 / 0.138 0.126 / 0.147 0.128 / 0.147 0.126 / 0.146 0.138 / 0.164 0.126 / 0.161 0.126 / 0.137 0.146 / 0.189 
No. atoms         
    Protein 3067 3045 3150 3165 3129 3034 3080 2980 
    Ligand/ion 54 38 60 30 27 31 81 47 
    Water 344 270 382 416 381 278 277 161 
B-factors (Å2)         
    Protein 16.4 17.3 16.3 16.6 18.4 20.6 16.4 27.8 
    Ligand/ion 16.8 22.4 16.4 17.4 22.8 25.3 18.1 26.3 
    Water 34.6 33.2 33.3 32.7 32.9 36.0 33.5 40.5 
R.m.s. deviations         
    Bond lengths 
(Å) 
0.0103 0.0091 0.0133 0.0113 0.0092 0.0111 0.0128 0.0142 
    Bond angles 
(q) 
1.539 1.424 1.772 1.557 1.391 1.493 1.411 1.411 
PDB ID 6FWG 6FWI 6FWJ 6FWL 6FWM 6FWO 6FWP 6FWQ 
*Values in parentheses are for highest-resolution shell
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Table S2 | Lengths (Å) of important bonds along the calculated reaction pathway.a 
 
 C1-O1 C1-O2 O1-HE336 OE336-HE336 O2-H2 H2-OE333 
0&¶ 1.53±0.05a 2.40±0.06 3.48±0.08 1.01±0.05 0.99±0.03 2.12±0.28 
MC 1.47±0.05 2.48±0.07 2.89±0.10 1.03±0.04 1.00±0.02 1.96±0.25 
TS 1.88±0.06 2.29±0.06 1.25±0.05 1.23±0.04 1.04±0.03 1.64±0.10 
PT 3.1±0.13 2.1±0.14 1.01±0.04 1.77±0.09 1.18±0.17 1.40±0.20 
(32¶ 4.01±0.10 1.51±0.06 1.00±0.05 1.98±0.11 1.61±0.10 1.03±0.03 
EPO 4.03±0.09 1.51±0.07 1.00±0.04 3.50±0.07 1.59±0.11 1.03±0.03 
 
a
 Standard deviation 
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Table S3 | KIEs measured on BxGH99-catalyzed hydrolysis of Man4OMe at pH = 7.0, 
25°C. 
 
Effect Run 1 Run 2 Run 3 Run 4 Mean ± SD 
1-2H 1.129 ± 0.012 1.121 ± 0.009 1.118a - 1.123 ± 0.012 
1-13C 1.032 ± 0.002 1.030 ± 0.005 1.028a - 1.030 ± 0.005 
2-18O 1.052 ± 0.006 1.048 ± 0.007 1.055 ± 0.004 1.052 ± 0.005 1.052 ± 0.006 
a
 Fits from experiments containing more enzyme, which resulted in fewer data points 
and more scatter. 
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Fig. S1 | Superposition of the ±2/±1 subsite ligands in product complexes of wildtype and 
E333Q BxGH99. 
The product sits deeper in the binding cleft of the wildtype. Wildtype complex colored coral 
and E333Q mutant complex colored green. The models were aligned in ccp4mg1 using the 
mainchain atoms of residues 333 to 336. 
  
 39 
 
 
 
Fig. S2 | Comparison of substrate and product complexes showing reorganization in the 
active site.  
Structures of BxGH99 E333Q-bound (white) (Man)420HDQGJUH\Į-1,3-PDQQRELRVHĮ-
1,2-mannobiose. The arrow highlights the change in position of oxygen-2 of the +1 mannose. 
Figure assembled in ccp4mg.1 
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Fig. S3 | 'Electrophilic' migration of the anomeric carbon upon conversion of Michaelis 
complex to EPO via the transition state.  
Superposition of the calculated Michaelis (MC), transition state (TS) and 1,2-anhydro sugar 
(EPO) complexes highlight that major atomic movements involve C2, C1, O5 and C5.  
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Fig. S4 | Conformational states mapped on the Cremer-Pople projection. Conformation of 
the ±1 saccharide ring in the BxGH99 endo-Į-1,2-mannanase complexes investigated (both 
experiments and theory). 
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Fig. S5 | Reaction pathway obtained from QM/MM metadynamics simulation using 
alternative collective variables.  
The first collective variable accounts for the direct nucleophilic attack of E333 onto the 
anomeric carbon (formation of an OE333-C1 bond), whereas the second one accounts for the 
protonation of the glycosidic oxygen. Specifically, CV1 = d(OE333-C1)- d(C1-O1) and CV2 = 
d(OE336-HE336) ± d(HE336-O1). These are the CVs typically used to describe the double-
displacement reaction of retaining GHs.2 
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Fig. S6 | MDVVVSHFWURPHWU\GDWDIRUWKHȕ-epoxide reaction. 1 PM BtGH99 was incubated 
with the indicated amounts of epoxide mixture and the signals corresponding to (A) epoxide 
substrate and (B) diol product, were monitored over time. In (C) and (D), 20 PM BtGH99 
was used. Note that the signal for the epoxide does not get smaller after the 20 min 
measurement in the case of incubation with 20 ȝ0HQ]\PH (C) because the total available ȕ-
epoxide was consumed within approximately 6 min. BxGH99 was incubated with the 
indicated amounts of epoxide mixture and the signals corresponding (E) epoxide substrate 
and (F) diol product, were monitored over time. Values for controls (no enzyme, shades of 
green) were made negative for clarity. The small differences in apparent molecular mass are 
due to instrument recalibrations; a. i. ± arbitrary intensity units. The spectra for no enzyme 
controls at 20 and 60 min are largely overlapping. 
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Fig. S7 | Mass spectrometry data for GH99 reactivity of Glc-Į-1,2-aziridine, 
cyclohexane-Į-1,2-epoxide, cyclohexane-E-1,2-aziridine and Glc-cyclohexene. Plots show 
concentrations of various substrates as a function of time when incubated with BtGH99, 
BxGH99 and BxGH99 E336Q. (A) Glc-Į-aziridine. (B) Glc-Į-epoxide. The outstanding point 
at 20 min is due to a larger experimental error caused by a smaller overall concentration of 
ligand in this particular sample. (C) Glc-ȕ-aziridine: falling line; hydrolysis product: rising 
line. The ȕ-aziridine was unstable in solution, and its rate of hydrolysis was not altered by 
enzyme. (D) Area of peaks corresponding to Glc-cyclohexene.3 This ligand is not a substrate 
for the enzyme. The concentration could not be estimated due to the lack of a peak 
corresponding to a hydrolysis product. (E) Structures of cyclohexane-Į-1,2-epoxide (1), 
cyclohexane-Į-1,2-aziridine (3), and Glc-cyclohexene. 
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Fig. S8 | NMR titration of BtGH99 with cyclohexane ȕ-1,2-aziridine. 
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Fig. S9 | Superposition of models of BxGH99 complexed with intermediate mimics. Light 
green: cyclohexane ȕ-1,2-epoxide with E333Q mutant; green: cyclohexane ȕ-1,2-aziridine 
with wildtype; JROGȕ-epoxide with wildtype; JUH\ȕ-epoxide with E336Q mutant (note the 
dual conformations of Q336). The models were aligned in ccp4mg1 using the main chain atoms 
of residues 333 to 336. 
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Fig. S10 | Thin layer chromatography of the GH99-mediated transglycosylation 
reaction. The epoxides present in the reaction mixture are labelled on the top of the lane. The 
DFFHSWRUĮ-1,2-mannobiose) is present at the same concentration in all lanes except 2, 3 and 
6. The synthesis of GlcMan3OMe will be reported elsewhere. 
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Fig. S11 | Proposed mechanism of endomannosidase-mediated pseudotetrasaccharide 
formation using the cyclohexane ȕ-1,2-epoxide used as the donor. The residue numbering 
refers to BxGH99 protein. 
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Fig. S12 | Deuterium kinetic isotope effects. Change in isotopologue ratio (R 1-2H/1-1H) vs. 
F1 for the GH99-catalyzed hydrolysis of Man4OMe. (Left) data from expt. 1; (right) data 
from expt. 2. Also shown is the non-linear least squares fit to eqn 1. 
  
 50 
 
 
Fig. S13 | 13C kinetic isotope effects. Change in isotopologue ratio R (1-13C/1-12C) vs. FL for 
the GH99-catalyzed hydrolysis of Man4OMe. (Left) data from expt. 1; (right) data from expt. 
2. Also shown is the non-linear least squares fit to eqn 1. 
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Fig. S14 | Change in isotopologue ratio R (2-18O/2-16O) vs. FL for the GH99-catalyzed 
hydrolysis of Man4OMe. (Top left) data from expt. 1; (top right) data from expt. 2; (bottom 
left) data from expt. 3; (bottom right) data from expt. 4. Also shown is the non-linear least 
squares fit to eqn 1. 
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Safety statement 
No unexpected or unusually high safety hazards were encountered in this work. 
 
Crystal handling, X-ray crystallography and structure solution 
Crystals of BxGH99 were grown in 3 M sodium acetate, pH 6.4-7.4 at 19 ºC in darkness using 
the hanging drop vapor diffusion method. Soaking (30 min) was performed by adding a 0.5-
1 µl concentrated (20-50 mM) aqueous solution of a ligand to the droplet. In the case of the 
structure of wild-type Bx*+ ZLWK ȕ-epoxide, the crystals were soaked for 3 PLQ $OO ȕ-
epoxide soaks were performed at pH 7.4 to minimize acid-catalyzed reactions. Data reduction 
was performed in xia2.1 The data were scaled and merged using aimless.2 Structures were 
solved by matching the HKL index of a dataset to that of 5M17 (PDB code) and direct 
refinement in REFMAC53 using only the polypeptide chain model. The Rfree set was kept 
identical to that in PDB 5M17. In all cases, the space group was the same (I4). Coot4 was used 
for model building and real-space refinement. The models were validated using Coot and 
edstats. Cremer-Pople parameters of sugars5 were obtained using Privateer,6 which was also 
used to validate their real space electron density correlation coefficient. Figures were made 
using ccp4mg.6-7 
 
Computational Methods 
Classical and QM/MM molecular dynamics simulations 
The initial structure for the simulations was taken from the structure of BxGH99-E333Q bound 
WR Į0DQ-1,3-Į0DQ-1,2-Į0DQ-1,2-Į0DQ-OMe [(Man)4OMe] reported in this work (PDB 
6FWG). To simulate the wild type enzyme, the mutation of the acid residue (Q333E) was 
manually reverted, and the substrate was modelled as (Man)4OH. The protonation states and 
hydrogen atom positions of all amino acid residues were taken according to their protein 
environment. Histidines 60, 63, 109 and 245 were considered as double protonated, His154 
DQG+LVZHUHSURWRQDWHGDW1İDQG+LVZDs protonated at Nį. A total number of 22.240 
water molecules were added to the protein surface, within a radius of 15 Å from the protein. 
Molecular dynamics (MD) simulations were performed using the Amber11 software.10 
The protein was modeled using the FF99SB force field.11 The carbohydrate substrate and water 
molecules were described with the GLYCAM0611 and TIP3P12 force fields, respectively.12-13 
The MD simulation was carried out in several steps. First, the system was minimized, holding 
the protein and substrate fixed, followed by energy minimization on the entire system. To 
gradually reach the desired temperature, weak spatial constraints were initially added to the 
 55 
 
protein and substrate, while water molecules were allowed to move freely at 100 K. The 
constraints were then applied only to the catalytic residues and the working temperature of 
300K was reached after four more 50 K heating steps in the NVT ensemble. Afterwards, the 
density was converged up to water density at 300 K in the NPT ensemble and the simulation 
was extended to 30 ns in the NVT ensemble, releasing the restraints on the the two catalytic 
residues during the last 15 ns. 
Analysis of the trajectory was carried out using standard tools of AMBER and VMD.14 
QM/MM MD simulations were performed using the method developed by Laio et al.,15 which 
combines Car±Parrinello MD,16 based on Density Functional Theory (DFT), with force-field 
MD methodology. In this approach, the system is partitioned into quantum mechanics (QM) 
and molecular mechanics (MM) fragments. The dynamics of the atoms on the QM fragment 
depend on the electronic deQVLW\ȡUFRPSXWHGZLWK'HQVLW\)XQFWLRQDO7KHRU\ZKHUHDVWKH
dynamics of the atoms on the MM fragment are ruled by an empirical force field. The QM/MM 
interface is modeled by the use of link-atom that saturates the QM region. The electrostatic 
interactions between the QM and MM regions were handled via a fully Hamiltonian coupling 
scheme,15 where the short-range electrostatic interactions between the QM and the MM regions 
are explicitly taken into account for all atoms. An appropriately modified Coulomb potential 
was used to ensure that no unphysical escape of the electronic density from the QM to the MM 
region occurs. The electrostatic interactions with the more distant MM atoms were treated via 
a multipole expansion. Bonded and van der Waals interactions between the QM and the MM 
regions were treated with the standard AMBER force-field. Long-range electrostatic 
interactions between MM atoms were described with the P3M implementation,16 using a 64 x 
64 x 64 mesh. 
The QM region included all the atoms of the (Man)4OH substrate and the catalytic 
residues E333 and E336, leading a total number of 108 QM atoms (including capping 
hydrogens). The MM subsystem includes a total number of 72.235 MM atoms. The QM region 
was enclosed in an isolated supercell of size 19.4 x 17.9 x 23.7 Å3. Kohn±Sham orbitals were 
expanded in a planewave basis set with a kinetic energy cutoff of 70 Ry. Norm-conserving 
Troullier±Martins ab initio pseudopotentials17 were used for all elements. The calculations 
were performed using the Perdew, Burke and Ernzerhoff generalized gradient-corrected 
approximation (PBE).18 This functional form has been proven to give a good performance in 
the description of hydrogen bonds19 and carbohydrate conformations20 and was already used 
with success in previous works on glycoside hydrolases and glycosyltransferases.21 The 
fictitious electronic mass was set to 700 au and the timestep to 5 au. 
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QM/MM metadynamics simulations 
The free energy landscape (FEL) of the reaction was explored using the metadynamics 
approach22 with two collective variables (CVs). We used the metadynamics driver provided by 
the Plumed2 plugin.23 The first collective variable (CV1) was defined as the difference between 
the O2-C1 and the C1-O1 distances. This variable accounts for the nucleophilic attack of the 
2-OH to the anomeric center and the cleavage of the glycosidic bond. The second collective 
variable (CV2) was defined as the distance difference between the OE336-H and H-O1. This 
variable accounts for proton transfer between the acid/base residue and the glycosidic bond. 
Repulsive walls were set to 2.5 and -2.5 Å for each of the variables, with a constant of 150 
kcal/mol·Å2, to restrain the exploration to the reactive event. Symmetric Gaussians of 1 
kcal/mol height and 0.15 Å width were deposited every 30 fs (250 MD steps). Sampling of the 
FES was completed after 1049 deposited Gaussians.  
An additional metadynamics simulation was performed without including the O2 atom 
in the collective variables definition. In this case, the nucleophilic attack (CV1) was defined as 
the difference between the OE333-C1 and the C1-OGly distances, i.e. with E333 acting as a 
³FODVVLFDO´ QXFOHRSKLOH LQ D GRXEOH-displacement reaction. The same parameters as in the 
previous metadynamics simulation were used, adapting the wall on CV1 to the new boundaries 
(4.5 and -4.5 Å). The FES was completed after 805 deposited Gaussians. This simulation also 
conduced reactants towards the formation of the epoxide (Supplementary Fig. 5). 
 
&\FORKH[DQHȕ-1,2-epoxide transfer reaction and thin layer chromatography 
)RUDOOUHDFWLRQVIUHVKO\SUHSDUHGDTXHRXVVROXWLRQVRIĮ-1,2-HSR[LGHDQGȕ-1,2-epoxide were 
used and the buffer was 50 mM potassium phosphate pH 7.0, 185 mM KCl. Due to the 
GLIILFXOW\RIVHSDUDWLQJWKHF\FORKH[DQHĮ-1,2-HSR[LGHDQGȕ-1,2-epoxide, a mixture of both 
ZDVXVHGĮȕUDWLR*OF0DQ3OMe was used at 250 ȝ07KHUHDFWLRQVFRQWDLQHG ȝ0
of each enzyme and were incubated at 37 &IRUK7KHFRQFHQWUDWLRQRIF\FORKH[DQHĮ-1,2-
epoxide in the samples was 1 mM and the concentration of cyclohH[DQHȕ-1,2-epoxide, in the 
samples which contained it, was 0.56 P0 7KH FRQFHQWUDWLRQ RI WKH DFFHSWRU Į-1,2-
mannobiose, was 1 mM. The total reaction volume was 10 ȝO IRU7/&RU ȝO IRUmass 
spectrometry (MS)).  
The samples were transferred in 1 ȝOGroplets onto SUPELCO silica gel on TLC Al 
foils (Sigma Aldrich). Each droplet was allowed to dry before adding the next droplet. A total 
of 5 ȝO for each lane was loaded onto the silica gel. TLC was performed in a preequilibrated 
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chamber using 50% v/v n-butanol, 25% v/v acetic acid, 25% v/v H2O as the eluent. When the 
eluent reached 75% of the plate height, the plate was taken out of the chamber, dried and run a 
second time to allow better compound resolution. The eluent was allowed to reach 75% of the 
plate height, at which point the migration was terminated. After drying, the samples were 
visualized by applying a staining solution (3% v/v sulfuric acid, 75% v/v ethanol, 0.1% orcinol 
monohydrate). The spots appeared after the plate was dried and subsequently heated on a hot 
plate (70±100 °C). 
 
Epoxide hydrolysis and transfer reactions and mass spectrometry 
Reactions were conducted at 37 ºC in 1.25 µM HEPES pH 7.0, 5 mM NaCl. Samples were 
taken after 20 min, 60 min and an overnight wait: 17-22 h. Quenching was achieved by mixing 
10 µl reaction mixture with 100 µl methanol. Compounds were incubated in separate reaction 
tubes with 1 µM of each of wild-type BtGH99, wild-type BxGH99, BxGH99 E333Q, BxGH99 
E336Q; 20 µM of wild-type BtGH99; or buffer only. MS were obtained using a Bruker 
microTOF spectrometer using electrospray ionization (ESI). All compounds were used at a 
starting concentration of 1 mM with correction factors from calculations applied later. The 
peaks corresponding to the [M+Na]+ ions were integrated in Origin software (OriginLab). The 
concentration of the compounds was estimated as follows: the areas of the peaks corresponding 
to unreacted epoxide or aziridine and their ring-opened forms in each mass spectrum were 
added and assumed to be 1 mM. The area of each peak was divided by the total area and this 
ZDVWKHUHSRUWHGFRQFHQWUDWLRQ,QWKHFDVHRIWKHȕ-epoxide, extended digestion with enzyme 
revealed that a portion of the substrate peak was not processed by the enzyme ± most likely 
WUDFHVRIĮ-1,2-HSR[LGH7KLVDPRXQWZDVVXEWUDFWHGIURPWKHWRWDOFDOFXODWHGF\FORKH[DQHȕ-
1,2-HSR[LGHFRQFHQWUDWLRQ$GGLWLRQDOO\ȕ-HSR[LGHDQGȕ-aziridine were not stable. We have 
included the starting amount of cyclohexane-diol in our calculations of reaction rate. 
)RUWKH06RIȕ-1,2-HSR[LGHWUDQVIHUUHDFWLRQȝORIWKHUHDFWLRQPL[WXUH used in the 
TLC experiment was used for permethylation, during which a procedure by Ciucanu and 
Kerek8 was followed. The products of the reaction were analyzed by MALDI-MS. The mass 
spectra are presented below. 
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0DVVVSHFWUXPRIWKHȕ-1,2-epoxide incubated in presence of BxGH99Į-1,2-epoxide 
and Į-1,2-mannobiose. Note the peak at m/z 883.4, corresponding to a sodiated, 
permethylated pseudotetrasaccharide species. 
 
0DVVVSHFWUXPRIWKHĮ-1,2-epoxide incubated in presence of BtGH99 and Į-1,2-
mannobiose. 
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0DVVVSHFWUXPRIWKHȕ-1,2-epoxide incubated in presence of Bt*+Į-1,2-epoxide and 
Į-1,2-mannobiose. Note the peak at m/z 883.4, corresponding to a sodiated, permethylated 
pseudotetrasaccharide species. 
 
Mass spectrum of the permethylation reaction blank sample. 
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NMR analysis of BtGH99-FDWDO\]HGK\GURO\VLVRIWKHȕ-epoxide (1). 
 1H and 13C 1-D NMR spectra of the product of the enzyme-GLJHVWRIWKHȕ-1,2-epoxide were 
obtained on a Bruker Avance 600 MHz instrument. Binding kinetics were determined as 
described earlier.9  
 
 
 
NMR data for 5: 1H-NMR (600 MHz, D22į±1.77 (2 H, m, H5a,5b), 2.00 (1 H, s), 
1.94 (1 H, m, H5), 3.47 (1 H, t, J2',3' = 9.9 Hz, H3'), 3.60 (1 H, dd, J2',3' = 9.9, J1',2' = 3.9 Hz, 
H2'), 3.76 (2 H, dd, Ja,b = 7.6, 4.6 Hz, H6a',6b'), 3.80±3.86 (4 H, m, H3,5',4,6b), 3.90 (2 H, d, 
J4',5' = 11.2 Hz, H4',6a), 4.05 (1 H, m, H1), 4.16 (1 H, t, J1,2 = 2.9, J2,3 = 5.8 Hz, H2), 5.25 (1 
H, d, J1',2' = 3.9 Hz, H1'). 13C NMR (151-MHz, D22į&D&&
62.4 (C6'), 69.2 (C1), 69.64 (C3), 69.57 (C5'), 71.9 (C2'), 72.3 (C4), 72.4 (C2), 73.0 (C4'), 
81.4 (C3), 100.8 (C1'). 
 
KIE Measurements 
1-2H-KIE measurements: Competitive V/K KIEs were measured using 13C NMR 
spectroscopy on a Bruker AVANCE II 600 MHz spectrometer with a 5 mm QNP cryoprobe.24  
Carbon-13 T1 values were measured for phenyl 1-thio-ȕ-D-(1-13C)glucopyranoside (internal 
standard), 1-13CMan4OMe and 1-13C,1-2H-Man4OMe at 25°C and pH 7.0 using a standard 
inversion recovery pulse sequence modified to add simultaneous 1H and 2H inverse gated 
decoupling and determined to be 1.049 s, 0.437 s and 2.533 s, respectively. In a typical 
experiment, a mixture of two labelled Man4OMe isotopologues (a1.0 mg of each) and phenyl 
1-thio-ȕ-D-(1-13C)glucopyranoside (0.25 mg) was dissolved in 590 µL buffer (25 mM HEPES, 
pH 7.0, 10% v/v D2O) and transferred into a standard 5 mm glass NMR tube. Reactions were 
initiated by the addition of a stock solution of enzyme (10 µL of 10 mg mL±1; final 
concentration of enzyme 3.86 µM. The magnetic field was shimmed to obtain symmetrical (as 
close to a Lorentzian shape as possible) peaks. 1H NMR and 13C NMR spectra were then 
acquired before sequentially acquiring more than hundred quantitative 13C NMR spectra with 
simultaneous inverse-gated proton- and deuterium-decoupling.25-26 FIDs were acquired for 36 
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scans (acquisition time per scan of 1.42 s) with a relaxation delay of 23.5 s (15 min per 
spectrum). 
The resultant quantitative 13C spectra were deconvolved by performing the following 
operations: i) Fourier transformation of the FIDs was performed with two-fold zero-filling and 
application of an exponential line broadening of 1.0 Hz; ii) spectra were manually phased and 
baseline corrected using MestReNova version 9; iii) spectra were fit using standard 
MestReNova line fitting algorithm for a generalized Lorentzian line shape; iv) to optimize the 
calculated fit peak positions, peak widths at half-height, peak heights and optimal combination 
of Lorentzian and Gaussian (L/G) shapes for each individual peak were allowed to vary; and 
v) the peak areas were normalized relative to that of the internal standard. Then, for each 
spectrum the fraction of reaction (FL) for the lighter isotopologue and the associated R values 
were calculated from the respective integrals. These data were fit to equation (1) using 
GraphPad Prism 8.02 and a non-linear least squares regression.27  ܴ ൌ ܴ଴ሺ ? െ ܨ୐ሻሺଵ ௄ூாିଵሻ ? ሺ ?ሻ 
 
2-18O-KIE measurements: Carbon-13 T1 value was measured for labelled 2-13CMan4OMe at 
25 °C and pH 7.0 using a standard inversion recovery pulse sequence and determined to be 
0.420 s. In a typical experiment, a mixture of two labelled Man4OMe isotopologues, 2-
13CMan4OMe and 2-13C,2-18O-Man4OMe (a1.0 mg of each), and phenyl 1-thio-ȕ-D-(1-
13C)glucopyranoside (0.25 mg) was dissolved in 650 µL buffer (25 mM HEPES, pH 7.0, 10% 
v/v D2O) and transferred into a standard 5 mm glass NMR tube. Reactions were initiated by 
the addition of enzyme (4±6 µL of a 2.3 mg mL±1 stock solution). The magnetic field was 
shimmed to obtain symmetrical (as close to a Lorentzian shape as possible) peaks. A 1H NMR 
and 13C NMR spectra were then acquired before sequentially acquiring more than fifty 
quantitative proton-decoupled 13C NMR spectra using an inverse-gated pulse sequence.2,3 FIDs 
were acquired for 128 scans (acquisition time per scan of 2.99 s) with a relaxation delay of 8.5 
s (24.5 min per spectrum). After the reaction had reached a50±80% completion, which 
occurred after a48±50 hours, an additional 20 PL of GH99 enzyme was added to ensure 
complete hydrolysis of the starting material.  Subsequently, a quantitative 13C{1H} spectrum 
of the products and the unreactive impurity was collected by accumulating 6000 scans. 
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The resultant quantitative 13C spectra were deconvolved by performing the following 
operations: i) Fourier transformation of the FIDs was performed with two-fold zero-filling and 
application of an exponential line broadening between 0.3±0.5 Hz; ii) Spectra were manually 
phased and baseline corrected using MestReNova version 10.0.2 and the chemical shift of the 
anomeric carbon signal of the internal standard phenyl 1-thio-ȕ-D-(1-13C)glucopyranoside was 
set to be 87.18 ppm; iii) Every 5 spectra were summed and the internal standard peaks were fit 
using standard MestReNova line fitting algorithm for a generalized Lorentzian line shape. To 
optimize the calculated fit peak positions, peak widths at half-height, peak heights and optimal 
combination of Lorentzian and Gaussian (L/G) shapes for each individual peak were allowed 
to vary; iv) Internal standard signal intensities, for each summed spectrum and the completely 
hydrolyzed final sample, were normalized and a difference spectrum was calculated. For every 
reaction summed spectrum obtained (see part 3) the difference spectrum was used to calculate 
R; v) The starting materials' peak areas were normalized relative to that of the internal standard. 
Then, for each spectrum the fraction of reaction (FL) for the lighter isotopologue and the 
associated R values (ratio of heavy/light isotopologues) were calculated from the respective 
integrals. These data were then fit using GraphPad Prism 8.02 and a non-linear least squares 
regression to equation 1.4 
1-13C-KIE measurements: Competitive V/K KIEs were measured using 13C NMR 
spectroscopy on a Bruker AVANCE III 600 MHz spectrometer with a 5 mm QCI cryoprobe.1  
Carbon-13 T1 values were measured for phenyl 1-thio-ȕ-D-(1-13C)glucopyranoside (internal 
standard), 2-13CMan4OMe and 1,2-13CMan4OMe at 25 °C and pH 7.0 using standard inversion 
recovery pulse sequence and determined to be 0.929 s, 0.391 s and 0.379 s, respectively. In a 
typical experiment, a mixture of two labelled Man4OMe isotopologues (a1.0 mg of each) and 
phenyl 1-thio-ȕ-D-(1-13C)glucopyranoside (0.25 mg) was dissolved in 650 µL buffer (25 mM 
HEPES, pH 7.0, 10% v/v D2O) and transferred into a standard 5 mm glass NMR tube. 
Reactions were initiated by the addition of enzyme (10±15 µL of 2.3 mg mL±1). The magnetic 
field was shimmed to obtain symmetrical (as close to a Lorentzian shape as possible) peaks. A 
1H NMR and 13C NMR spectra were then acquired before sequentially acquiring more than 
fifty quantitative proton-decoupled 13C NMR spectra using an inverse-gated pulse sequence.2,3 
FIDs were acquired for 128 scans (acquisition time per scan of 1.73 s) with a relaxation delay 
of 8.5 s (21.8 min per spectrum). After reaction reached 70±80% completion an additional 
quantity of GH99 enzyme (20 PL of 2.3 mg mL±1) was added to ensure full transformation of 
the starting material. Then a quantitative 13C{1H} spectrum of products and the unreactive 
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impurities was collected by accumulating 6000 scans. All data manipulations were performed 
in an identical manner as described above. 
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General synthetic methods 
Pyridine was distilled over KOH or CaH2. Dichloromethane was freshly distilled from P2O5, 
and THF distilled from sodium/benzophenone, or alternatively were dried over alumina 
according to the method of Pangborn et al.28 DMF was dried over molecular sieves. Reactions 
were monitored using TLC, performed with silica gel 60 F254. Detection was effected by 
charring in a mixture of 5% sulfuric acid in methanol, 10% phosphomolybdic acid in EtOH, 
and/or visualizing with UV light. Flash chromatography was performed according to the 
method of Still et al.29 XVLQJVLOLFDJHO>Į@D values are given in deg 10í cm2 gí. NMR 
experiments were conducted on 400, 500 or 600 MHz instruments, with chemical shifts 
referenced relative to residual protiated solvent and are in G ppm. Assignments were aided by 
2D 1+í1H COSY, HSQC, HMQC, HMBC, NOESY and TOCSY experiments. High resolution 
mass spectra were acquired in the ESI-QTOF or ESI-FTMS modes, or using a Bruker 
microTOF spectrometer, using Agilent ESI-L Low Concentration Tuning-Mix as reference. 
For oligosaccharides, the sugar rings leading away from the reducing end are denoted ', '', and 
''', respectively.  
 
Synthesis of cycloalkene 7, and epoxides 1 and 3. 
 
 
(3R,4R,5R)-3-Į-D-Glucopyranosyloxy-4-hydroxyl-5-(hydroxymethyl) cyclohexene (7)  
Ammonia (10 mL) was condensed at -60 °C. Lithium (100 mg) was added piece-wise and the 
mixture was stirred for about 20 min until the lithium was completely dissolved, to give a dep-
blue solution. A solution of 630 (97.8 mg, 0.147 mmol) in THF (5 mL) was added dropwise to 
the blue solution. The reaction was stirred for 30 min at -60 °C and then quenched with water 
(4 mL). This solution was stirred at r.t. overnight until all ammonia had evolved. Next, the 
solution was evaporated, then re-dissolved in water and neutralized with Amberlite IR 120/H+. 
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The solution was filtered and washed with water. Product 7 (40 mg, 95%) was obtained after 
lyophilisation of the combined eluate as a white amorphous solid. Rf = 0.28 (CH2Cl2-MeOH 
10:4); [Į]D20 47.6 (c 1.0 in H2O). 1H-NMR (400 MHz, D2O) į = 5.97-5.87 (m, 1H, H-1), 5.76-
5.66 (m, 1H, H-2), 5.29 (d, J1,2 = 3.9 Hz, 1H, H-1'), 4.33-4.27 (m, 1H, H-3), 3.93-3.77 (m, 5H, 
H-6'a, H-5', H-4, H-6a, H-6'b), 3.77-3.70 (m, 2H, H-3', H-6b), 3.60 (dd, J1,2 = 3.9 Hz, J2,3 = 9.9 
Hz, 1H, H-2'), 3.46 (t, J3,4, J4,5 = 9.4 Hz, 1H, H-4'), 2.36-2.24 (m, 1H, H-5aa), 2.11-1.96 (m, 
2H, H-5ab, H-5). 13C-NMR (100.6 MHz, D2O) į = 129.91 (C-1), 126.03 (C-2), 99.30 (C-1'), 
81.12 (C-3), 73.01 (C-3'), 72.38 (C-4), 72.18 (C-5'), 71.57 (C-2'), 69.68 (C-4'), 62.42 (C-6), 
60.61 (C-6'), 40.46 (C-5), 27.39 (C-5a). ESI-HRMS (m/z) calcd for C13H22O8Na (M + Na+) 
329.1207, found: 329.1204. 
  
 (1R,2R,3R,4R,5R)-1,2-ȕ-Anhydro-3-Į-D-glucopyranosyloxy-4-hydroxyl-5-
(hydroxymethyl) cyclohexane (1) and (1S,2S,3R,4R,5R)-1,2-Į-Anhydro-3-Į-D-
glucopyranosyloxy-4-hydroxyl-5-(hydroxymethyl) cyclohexane (3) 
A solution of 7 (47 mg, 0.154 mmol, 1eq) in aqueous Na2EDTA solution (4.5 mL, 4×10-4 M) 
and CH3CN (3 mL) was cooled to 0-2 °C, followed by addition of trifluoroacetone (0.14 mL, 
1.54 mmol, 10 eq) via a precooled syringe. To this solution was added a mixture of NaHCO3 
(100 mg, 1.19 mmol, 7.8 eq) and Oxone (236 mg, 0.76 mmol, 5 eq) portionwise over 1 h. The 
reaction mixture was stirred for another 1 h, and then concentrated. The resulting solid was 
redissolved in methanol, and centrifuged to keep the clear organic solution, which was then 
concentrated again. The residue was purified by silica gel column chromatography (EtOAc-
iPrOH-H2O 13:5:0.36). Product 3 (30 mg, 61%) and 1 (11 mg, 22%) were isolated and obtained 
as white amorphous solids.  
Product 3: Rf = 0.41 (EtOAc-iPrOH-H2O 5:10:1); [Į]D20 79.3 (c 0.3 in H2O). 1H-NMR (400 
MHz, D2O) į = 5.29 (d, J1,2 = 3.8 Hz, 1H, H-1'), 3.90-3.70 (m, 5H, H-6'a, H-5', H-3, H-6'b, H-
3'), 3.69-3.64 (m, 2H, H-6a, H-6b), 3.58 (dd, J1,2 = 3.8 Hz, J2,3 = 9.5 Hz, 1H, H-2'), 3.51 (dd, 
J4,5 = 11.5 Hz, J3,4 = 8.2 Hz, 1H, H-4), 3.46-3.41 (m, 2H, H-4', H-1), 3.39 (d, J1,2 = 3.8 Hz, 1H, 
H-2), 2.29-2.20 (m, 1H, H-5aa), 1.90-1.77 (m, 1H, H-5ab), 1.61-1.51 (m, 1H, H-5). 13C-NMR 
(100.6 MHz, D2O) į = 101.05 (C-1'), 80.53 (C-3), 73.44 (C-3'), 73.13 (C-5'), 72.55 (C-4), 72.17 
(C-2'), 70.20 (C-4'), 62.32 (C-6), 61.20 (C-6'), 56.27 (C-2), 54.96 (C-1), 34.93 (C-5), 26.77 (C-
5a). ESI-HRMS (m/z) calcd for C13H22O9Na (M + Na+) 345.1156, found: 345.1156.  
Product 1: Rf = 0.29 (EtOAc-iPrOH-H22>Į@D20 85.5 (c 0.1 in MeOH). 1H-NMR (400 
MHz, CD3OD) į = 5.17 (d, J1,2 = 3.8 Hz, 1H, H-1'), 3.93 (ddd, J4,5 = 9.9 Hz, J5,6a = 5.4 Hz, 
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J5,6b = 2.4 Hz, 1H, H-5'), 3.89-3.81 (m, 2H, H-6'a, H-3), 3.79-3.72 (m, 2H, H-3', H-6'b), 3.72-
3.66 (m, 2H, H-6a, H-4), 3.65-3.57 (m, 2H, H-6b, H-2), 3.49 (dd, J1,2 = 3.8 Hz, J2,3 = 9.8 Hz, 
1H, H-2'), 3.39-3.35 (1H, H-4'), 3.33 (dd, J1,2 = 4.3 Hz, J1,5a = 8.9 Hz, 1H, H-1), 2.18 (dt, J5aa,5ab 
= 14.8 Hz, J5,5aa, J1,5aa = 5.5 Hz, 1H, H-5aa), 1.81 (dd, J5aa,5ab = 14.8 Hz, J5,5ab= 11.7 Hz, 1H, 
H-5ab), 1.79-1.68 (m, 1H, H-5). 13C-NMR (151 MHz, CD3OD) į = 102.69 (C-1'), 85.53 (C-
3), 75.08 (C-3'), 74.02 (C-2'), 73.93 (C-5'), 71.83 (C-4'), 71.09 (C-4), 63.78 (C-6), 62.70 (C-
6'), 57.52 (C-2), 54.65 (C-1), 42.27 (C-5), 27.26 (C-5a). ESI-HRMS (m/z) calcd for 
C13H22O9Na (M + Na+) 345.1156, found: 345.1147. 
 
Synthesis of aziridine 2. 
 
 
 
(1R,2S,3R,4R,5R)-1-Azido-2-hydroxyl-3-(2,3-di-O-benzyl-4,6-O-benzylidene-Į-D-
glucopyranosyloxy)-4-benzyloxy-5-(benzyloxymethyl) cyclohexane (9) and 
(1S,2R,3R,4R,5R)-1-Hydroxyl-2-azido-3-(2,3-di-O-benzyl-4,6-O-benzylidene-Į-D-
glucopyranosyloxy)-4-benzyloxy-5-(benzyloxymethyl) cyclohexane (10) 
A solution of epoxide 830 (75 mg, 0.097 mmol, 1 eq) in 8:1 MeOH/H2O (9 mL) was treated 
with NaN3 (120 mg, 1.85 mmol, 19 eq) and NH4Cl (21 mg, 0.389 mmol, 4 eq). The reaction 
mixture was stirred at 80 °C for 72 h, diluted with ether, washed with saturated NaHCO3 and 
brine, dried over MgSO4 and concentrated to afford crude azides 9 and 10 (67 mg) for the next 
step without further purification. 
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(1R,2R,3R,4R,5R)-1,2-ȕ-Aziridine-3-(2,3-di-O-benzyl-4,6-O-benzylidene-Į-D-
glucopyranosyloxy)-4-benzyloxy-5-(benzyloxymethyl) cyclohexane (11) 
To a solution of azides 9 and 10 (67 mg) from the above step in THF (10 mL), PPh3 (32.4 mg, 
0.124 mmol) was added and the resulting solution was stirred at r.t. for 30 min, then refluxed 
for 24 h. The solvent was evaporated and purification by silica gel chromatography 
(Cyc/EtOAc 2:1) afforded E-aziridine 11 (33 mg, 52%) as a white amorphous foam. Rf = 0.26 
(Cy-(W2$F>Į@D20 9.4 (c 0.1 in CHCl3). 1H-NMR (400 MHz, CDCl3) į = 7.53-7.47 (m, 
2H, arom), 7.42-7.14(m, 23H, arom), 5.56 (s, 1H, PhCH), 5.12 (d, J1,2 = 3.8 Hz, 1H, H-1'), 
5.08, 4.45 (2d, Jgem = 11.5 Hz, 2H, PhCH2), 4.93, 4.84 (2d, Jgem = 11.6 Hz, 2H, PhCH2), 4.74, 
4.65 (2d, Jgem = 12.2 Hz, 2H, PhCH2), 4.42 (s, 2H, PhCH2), 4.32-4.12 (m, 3H, H-5', H-3', H-
6'a), 3.93 (dd, J3,4 = 8.2 Hz, J2,3 = 3.6 Hz, 1H, H-3), 3.71 (t, J6a,6b, J5,6b = 10.2 Hz, 1H, H-6'b), 
3.63 (t, J3,4, J4,5 = 9.4 Hz, 1H, H-4'), 3.56 (dd, J1,2 = 3.7 Hz, J2,3 = 9.4 Hz, 1H, H-2'), 3.58-3.47 
(m, 2H, H-4, H-6a), 3.46-3.35 (m, 1H, H-6b), 2.58 (dd, J2,3 = 3.6 Hz, J1,2 = 6.1 Hz, 1H, H-2), 
3.25 (dd, J1,2 = 6.1 Hz, J1,5a = 6.3 Hz, 1H, H-1), 2.28-2.12 (m, 1H, H-5aa), 1.85-1.74 (m, 2H, 
H-5, H-5ab). 13C-NMR (100.6 MHz, CDCl3) į = 139.47, 138.85, 138.74, 138.41, 137.66 (arom 
C), 129.05, 128.42, 128.39, 128.38, 128.34, 128.25, 128.19, 127.94, 127.83, 127.66, 127.54, 
127.23, 126.30 (arom CH), 101.56 (PhCH), 100.40 (C-1'), 84.68 (C-3), 82.68 (C-4'), 79.38 (C-
2'), 78.38 (C-3'), 78.19 (C-4), 75.23 (PhCH2), 75.00 (PhCH2), 73.54 (PhCH2), 73.19 (PhCH2), 
70.73 (C-6), 69.32 (C-6'), 63.06 (C-5'), 40.78 (C-5), 36.22 (C-2), 31.19 (C-1), 28.31 (C-5a). 
ESI-HRMS (m/z) calcd for C48H52NO8Na (M + Na+) 770.3687, found: 770.3706.  
 
(1R,2R,3R,4R,5R)-1,2-ȕ-Aziridine-3-Į-D-glucopyranosyloxy-4-hydroxyl-5-
(hydroxymethyl) cyclohexane (2)  
Ammonia (7 mL) was condensed at -60 °C. Lithium (50 mg) was added piece-wise and the 
mixture was stirred for about 20 min until the lithium was completely dissolved. A solution of 
11 (10 mg, 0.130 mmol) in THF (2.5 mL) was added dropwise to the mixture. The reaction 
was stirred for 30 min at -60 °C and then quenched with water (2 mL). This solution was stirred 
at r.t. overnight until all ammonia had evolved. Next, the solution was evaporated, then re-
dissolved in water and neutralized with Amberlite IR 120/H+. The solution was filtrated and 
washed with water. Then, the resin was eluted with 1 M NH4OH solution (8 mL× 4), and the 
filtrate was evaporated under reduced pressure. The resulting solid was re-dissolved in water 
and neutralized with Amberlite-NH4+, and then filtered and washed with water. Target product 
2 (3.8 mg, 95%) was obtained after lyophilisation of the combined eluate as a white amorphous 
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solid. Rf = 0.38 (EtOAc-iPrOH-H2O 5:10:6); [Į]D20 79.0 (c 0.03 in H2O). 1H-NMR (400 MHz, 
D2O) į = 5.24 (d, J1,2 = 3.8 Hz, 1H, H-1'), 3.99-3.93 (m, 1H, H-5'), 3.93-3.87 (m, 1H, H-3), 
3.87-3.78 (m, 3H, H-3', H-6'a, H-6'b), 3.70 (dd, J6a,6b = 11.3 Hz, J5,6a = 4.1 Hz, 1H, H-6a), 3.60 
(dd, J1,2 = 3.8 Hz, J2,3 = 9.8 Hz, 1H, H-2'), 3.59-3.50 (m, 2H, H-6b, H-4), 3.47 (t, J3,4, J4,5 = 9.8 
Hz, 1H, H-4'), 2.74 (dd, J2,3 = 3.8 Hz, J1,2 = 6.0 Hz, 1H, H-2), 2.55 (t, J1,2, J1,5a = 7.1 Hz, 1H, 
H-1), 2.25-2.16 (m, 1H, H-5aa), 1.80-1.67 (m, 1H, H-5), 1.53 (dd, J5aa,5ab = 14.3 Hz, J5,5ab = 
12.5 Hz, 1H, H-5ab).  13C-NMR (100.6 MHz, CDCl3) į = 100.40 (C-1'), 83.74 (C-3), 72.99 
(C-3'), 72.14 (C-5'), 71.95 (C-2'), 70.60 (C-4), 69.72 (C-4'), 62.42 (C-6) 60.55 (C-6'), 40.96 (C-
5), 35.16 (C-2), 30.75 (C-1), 26.09 (C-5a). ESI-HRMS (m/z) calcd for C13H24NO8 (M + H+) 
322.1496, found: 322.1500.  
 
Preparation of (Man)4OMe isotopologues 
 
 
 
2,3,4,6-Tetra-O-acetyl-D-D-mannopyranosyl bromide31 (13)  
D-Mannose pentaacetate 12 (5.0 g, 12.8 mmol) was dissolved in a solution of hydrogen 
bromide (33% in acetic acid, 6 mL) the reaction mixture was stirred at r.t for 2 h, after which 
TLC analysis indicated complete consumption of the starting material. The reaction mixture 
was poured into ice water, and extracted with CH2Cl2 (3 × 75 mL). The combined organic 
phase was washed with brine (3 × 75 mL), sat. NaHCO3 (3 × 75 mL) and again with brine. The 
organic phase was dried over anhydrous MgSO4, filtered and evaporated in vacuo to afford 13 
(5.00 g, 97%) as a pale yellow oil. [Į@D22 +118° (c 0.8, CHCl3; lit.31 +122°); 1H-NMR (400 
MHz, CDCl3į× 3H, s, Me), 4.13 (1H, dd, J6,6a =12.4, J5,6a = 2.1 Hz, 
H6a), 4.21 (1H, ddd, J4,5 = 10.1, J5,6 = 4.9, J5,6a = 2.1 Hz, H5), 4.32 (1H, dd, J6,6a = 12.5, J5,6 = 
4.8 Hz, H6), 5.36 (1H, app. t, J3,4 = J4,5 =10.1 Hz, H4), 5.43 (1H, dd, J2,3 = 3.5, J1,2 = 1.5 Hz, 
H2), 5.70 (1H, dd, J3,4 = 10.2, J2,3 = 3.5 Hz, H3), 6.29 (1H, d, J1,2 = 1.5 Hz, H1); 13C-NMR (101 
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MHz, CDCl3) į × 1C, Me), 61.3 (1C, C6), 65.2 (1C, C4), 67.8 (1C, 
C3), 72.0 (1C, C5), 72.7 (1C, C2), 83.0 (1C, C1), 169.4, 169.6, 169.6, 170.4 (4 × 1C C=O). 
 
3,4,6-Tri-O-acetyl-1,2-O-(methoxyethylidene)-E-D-mannopyranoside (14). 
The bromide 13 (2.1 g, 5.1 mmol) was dissolved in dry pyridine (4 mL), then dry methanol (2 
mL) was added and the solution was stirred overnight at room temperature. The solution was 
poured into ice-water (50 mL) and the aqueous phase extracted with CH2Cl2 (3 × 30 mL). The 
combined organic phase was washed with brine (50 mL), dried (MgSO4), filtered and 
concentrated. The residue was redissolved in toluene (50 mL) and the remaining pyridine 
removed by azeotropic distillation in vacuo. The resulting solid of 14 was used for the 
following step without further purification, m.p. 110±112 °C. 1H-NMR (400 MHz, CDCl3į
1.74, 2.05, 2.07, 2.12 (4 × 3H, s, Me), 3.28 (3H, s, OMe), 3.68 (1H, m, H5), 4.14 (1H, dd, J6,6a 
= 11.7, J5,6a =1.9 Hz, H6a), 4.24 (1H, dd, J6,6a = 11.7, J5,6 = 5.0 Hz, H6), 4.61 (1H, dd, J2,3 = 3.5, 
J1,2 = 2.5 Hz, H2), 5.15 (1H, dd, J3,4 =10.0, J2,3 = 3.5 Hz, H3), 5.30 (1H, app. t, J3,4 = J4,5 = 10.0 
Hz, H4), 5.49 (1H, d, J1,2 = 2.5 Hz, H1). 
 
3,4,6-Tri-O-benzyl-1,2-O-(methoxyethylidene)-E-D-mannopyranoside (15). 
A small piece of freshly cut Na metal was added to a solution of 14 (370 mg) in dry MeOH 
(3.5 mL), and the mixture was stirred at rt for 30 min. The solvent was evaporated and the 
residue redissolved in dry DMF (4 mL). The reaction was cooled to 0 °C, then NaH (60% in 
mineral oil, 245 mg, 6.1 mmol) was added and the mixture was stirred for 30 min. Benzyl 
bromide (0.55 mL, 4.59 mmol) was added dropwise and the slurry was stirred overnight. After 
18 h, TLC analysis indicated complete consumption of the starting material. Ice-water was 
slowly added to quench the excess NaH, and the mixture was extracted with toluene (3 × 20 
mL). The combined organic phase was dried (MgSO4), filtered and concentrated. Flash 
chromatography (EtOAc:hexane:Et3N, 25:74:1) gave 15 (430 mg, yield over two steps 85%) 
as an endo/exo mixture. Colorless needles, m.p. 76±78 °C. 1H-NMR (400 MHz, CDCl3į
(3 H, s, Me), 3.28 (3 H, s, OMe), 3.44±5.35 (13 H, m, H1,2,3,4,5,6a,6b and PhCH2), 7.24±7.89 
(15 H, m, Ar); 13C-NMR (101 MHz, CDCl3į&Me), 49.8 (1 C, OMe), 69.0±79.0 
(8C, C2-6 and PhCH2), 97.6 (1 C, C1), 124.0±138.2 (Ar).  
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2-O-Acetyl-3,4,6-tri-O-benzyl-D-mannopyranose (16) 
A suspension of compound 15 (430 mg, 0.86 mmol) in 80% AcOH (9 mL) was stirred 
overnight at rt. The resulting solution was poured into a mixture of toluene (20 mL) and water 
(20 mL). The organic phase was washed with brine, sat. NaHCO3, and water (×3), and then 
dried (MgSO4). The residue was concentrated, yielding 16 (420 mg, 95%) as a colorless syrup, 
mixture of anomers. 1H-NMR (400 MHz, CDCl3į+V0H+V0H±
3.82 (4 H, m), 3.95 (1 H, m), 4.12±4.15 (2 H, m), 4.54±4.64 (4 H, m), 4.68±4.71 (1 H, m), 
4.78±4.81 (1 H, m), 4.94±4.97 (1 H, m), 5.30 (1 H, s, H1E), 5.46 (1 H, s, H1D), 7.24±7.43 (15 
H, m, Ar); 13C-NMR (101 MHz, CDCl3į&0H
75.0, 77.6 (8 × C, C2-6 and PhCH2), 92.4 (1 C, C1), 127.7, 127.8, 128.0, 128.1, 128.3, 128.4, 
137.7, 137.9, 138.2 (18 C, Ar), 170.5 (1 C, C=O); HRMS (ESI)+ m/z 515.2049 [C29H32NaO7 
(M + Na)+ requires 515.2046]. 
 
2-O-Acetyl-3,4,6-tri-O-benzyl-D-mannopyranosyl trichloroacetimidate (17) 
The hemiacetal 16 (472 mg, 0.960 mmol) was dissolved in dry CH2Cl2 (20 mL) and cooled to 
&7ULFKORURDFHWRQLWULOHȝ/PPRODQG'%8ȝ/PPROZHUHDGGHGDQG
the resulting solution was stirred for 1 h at r.t. The solvent was evaporated under reduced 
pressure and the residue was purified by flash chromatography (EtOAc:hexane:Et3N, 2:8:0.1) 
to yield 16 (0.520 g, 85%) as a white foam. 1H-NMR (400 MHz, CDCl3į+V0H
3.70±3.73 (1 H, m), 3.83±3.86 (1 H, m), 3.99±4.05 (4 H, m), 4.49±4.60 (4 H, m), 4.67±4.75 (2 
H, m), 4.86±4.88 (1 H, m), 5.50 (1 H, s), 6.30 (1 H, d, H1D), 7.26±7.34 (15 H, m, Ar), 8.68 (1 
H, s, NH); 13C-NMR (101 MHz, CDCl3į
108.2, 127.6, 127.8, 128.3, 137.8, 143.5, 170.0. 
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Methyl 3,4,6-tri-O-benzyl-D-D-mannopyranoside32 (18) 
The orthoester 15 (200 mg, 0.39 mmol) was dissolved in dry MeOH (4 mL) and heated to 
reflux. Acetyl chloride (0.12 mL, 0.11 mmol) was then dropwise added. The solution was 
stirred for one day, then was concentrated under reduced pressure. The residue was dissolved 
in EtOAc (15 mL), and washed with sat. NaHCO3 (3 × 20 mL), then dried (MgSO4), filtered 
and concentrated. The crude residue was purified by flash chromatography (EtOAc:toluene, 
6:4), yielding 18 (180 mg, 99%) as a colourless oil. [Į@D20 +49° (c 1.0, CHCl3; lit.32 +50.7°); 
1H-NMR (400 MHz, CDCl3į+GJ2,OH = 3.5 Hz , OH), 3.35 (3 H, s, OMe), 3.69±
3.76 (3 H, m, H5,6a,6b), 3.79±3.87 (2 H, m, H3,4), 4.00±4.02 (1 H, m, H2), 4.50, 4.53, 4.64, 
4.66, 4.69, 4.81 (6 × 1 H, m, PhCH2), 4.78 (1 H, d, J1,2 = 1.5 Hz, H1), 7.15±7.34 (15 H, m, Ar); 
13C-NMR (101 MHz, CDCl3į&2Me), 68.3 (1 C, C2), 69.0 (1 C, C6), 71.0, 74.3 (2 
C, C2,4), 72.0, 73.5, 75.0 (3 C, 3 × PhCH2), 80.2 (1 C, C3), 100.3 (1 C, C1), 127.5, 127.6, 
127.81, 127.84, 127.9, 128.3, 128.5, 138.0, 138.3, 138.4 (18 C, Ph); HRMS (ESI)+ m/z 
487.2090 [C28H32NaO6 (M + Na)+ requires 487.2097]. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(3,4,6-tri-O-benzyl-D-D-mannopyranosyl)-D-D-
mannopyranoside33 (19) 
A solution of 18 (250 mg, 0.54 mmol) and 17 (450 mg, 0.71 mmol) in dry toluene (20 mL) was 
stirred with freshly activated 4 Å molecular sieves for 1 h. The mixture was cooled to -30 °C 
and triflic acid (13 PL, 0.14 mmol) was added. The mixture was stirred for 60 min at -30 °C, 
then temperature was raised to -15°C. After 15 min, the reaction was quenched with Et3N (0.1 
mL), allowed to warm up to room temperature, filtered and the solvent evaporated under 
reduced pressure. The crude residue was purified by flash chromatography (EtOAc:hexane 
(1:19o3:7)), yielding a colourless oil (500 mg, 98%). The crude was dissolved in 
CH2Cl2:MeOH (20 mL), and a solution of MeONa (1 M in MeOH, 50 PL) was added. The 
solution was stirred for 30 min, after which TLC indicated completion of the reaction. The 
solution was neutralized with Amberlite 120R resin (H+ form) and the mixture filtered. The 
filtrate was concentrated under reduced pressure and purified by flash chromatography 
(EtOAc:hexane (1:19o3:7)), giving 19 (485 mg, 99%) as a colourless oil. [Į@D22 +24° (c 1.0, 
CHCl3; lit.33 +24.3°); 1H-NMR (400 MHz, CDCl3į+GJ2,OH = 1.7 Hz, OH), 3.25 (3 
H, s, OMe), 3.71±4.00 (11 H, m), 4.02 (1 H, m), 4.11 (1 H, m), 4.52±4.60 (5 H, m), 4.64±4.71 
(4 H, m), 4.75 (1 H, m), 4.79±4.94 +PV++ƍ+P$U13C-NMR 
(101 MHz, CDCl3į
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75.1, 75.2, 79.9, 80.1, 99.9, 101.2, 127.50, 127.56, 127.6, 127.7, 127.7, 127.8, 127.8, 127.8, 
127.9, 127.9, 127.9, 127.9, 127.9, 127.9, 128.0, 128.0, 128.0, 128.0, 128.0, 128.4, 128.4, 128.4, 
128.4, 128.4, 128.6, 138.1, 138.3, 138.4, 138.5, 138.6, 138.7; HRMS (ESI)+ m/z 897.4210 
[C55H61O11 (M + H)+ requires 897.4208]. 
 
 
 
2,3,4,6-Tetra-O-acetyl-D-mannopyranose (20) 
A solution of mannose pentaacetate 12 (1.0 g, 2.8 mmol) and benzylamine (416 PL, 3.8 mmol) 
in dry THF (6 mL) was stirred overnight at room temperature. The mixture was diluted with 
cold water and extracted with CH2CI2 (3 × 10 mL). The combined organic phase was then 
washed with 0.37 M HCI, saturated NaHCO3 and brine, dried (MgSO4), and concentrated. The 
crude was purified by flash chromatography (EtOAc:hexane, 2:3) to give 20 (0.73 g, 79%) as 
a mixture of anomers. 1H-NMR for the D-anomer (400 MHz, CDCl3į
(4 × 3 H, s, Me), 3.16 (1 H, d, JOH,1 = 4.0, OH), 4.13 (1 H, dd, 1 H, J6,6a =
 
8.0, J5,6 = 5.0 Hz, 
H6a), 4.24 (2 H, m, J5,6 = 5.0, J5,6a = 2.5 Hz, H5 and H6), 5.25 (1 H, dd, JOH,1 = 4.0, J1,2 =
 
1.8 
Hz, H1), 5.28 (1 H, dd, J2,3 = 3.2, J1,2 =
 
1.8 Hz, H2), 5.31 (1 H, app. t, J4,5 = J3,4 = 9.5 Hz, H4), 
5.43 (1 H, dd, J3,4 = 10.0,J2,3 = 3.2 Hz, H3); 13C NMR for the D-anomer (101 MHz,CDCl3į
20.9, 21.0, 21.0, 21.1 (4 C, Me), 62.8 (1 C, C6), 66.4, 68.7, 69.0, 70.3 (4 C, C2,3,4,5), 92.4 (1 
C, C1), 170.1, 170.4, 170.5, 171.2 (4 C, C=O). 
 
2,3,4,6-Tetra-O-acetyl-D-mannopyranosyl trichloroacetimidate (21) 
The hemiacetal 20 (1.00 g, 2.80 mmol) was dissolved in dry CH2Cl2 (50 mL), then CNCCl3 
(1.43 mL, 14.35 mmol) was added and the solution cooled to 0 °C. After 5 min, a catalytic 
amount of DBU (20 PL, 0.14 mmol) was added and the reaction warmed to room temperature. 
After 30 min, TLC analysis shown complete conversion of the starting material. The reaction 
was concentrated and the residue purified by flash chromatography (EtOAc:hexane:Et3N, 
(6:4:0.1)) to yield 21 (1.3 g, 92%) as a mixture of anomers, colourless oil. 1H-NMR for the D-
anomer (400 MHz, CDCl3į × 3 H, s, Me), 4.20 (3 H, m, H5,6,6a), 
5.40 (2 H, m, H3,4), 5.43 (1 H, m, H2), 6.28 (1 H, d, J1,2 = 1.8 Hz, H1), 8.79 (1 H, s, NH); 13C 
NMR for the D-anomer (101 MHz,CDCl3į × 1C, Me), 62.3 (1 C, 
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C6), 65.6, 68.1, 69.0, 71.5 (4 × 1C, C2,3,4,5), 94.8 (1 C, C1), 160.0 (s, CNH), 169.9, 170.0, 
170.1, 170.8 (4 × 1C, C=O). 
 
 
 
4-Methylphenyl 1-thio-Į-D-mannopyranoside34 (22). 
Mannose pentaacetate 12 (1.0 g, 2.6 mmol) and thiocresol (0.35 g, 2.8 mmol) were dissolved 
in dry CH2Cl2 (20 mL) and the solution cooled to 0 °C. BF3·OEt2 (0.32 ml, 2.6 mmol) was then 
added dropwise. The solution was allowed to warm to rt and was left to stir under N2 
atmosphere for 20 h. Sat. NaHCO3 was added and the mixture was diluted with CH2Cl2 and 
washed with sat. NaHCO3 (4 × 15 ml) and brine (15 ml). The organic phase was dried over 
anhydrous MgSO4, filtered and evaporated to afford the crude tetraacetate (1.58 g), which was 
used directly in the next step. The residue was dissolved in MeOH (45 mL), then a solution of 
NaOMe (1 M in MeOH, 1 mL) was added. The reaction was stirred for 1 h at rt, when TLC 
analysis indicated complete consumption of the starting material. Amberlite IR-120 resin (H+ 
form) was added to neutralise the solution and, following filtration, the solvent was evaporated 
to give a pale yellow solid. The residue was recrystallised from EtOAc:MeOH to afford the 
tetraol 22 (0.518 g, 71% over two steps) as white crystals, m.p. 138-&>Į@D22 +270° (c 
0.1, MeOH, lit.34 +279°); 1H-NMR (500 MHz, d6-'062į+V&+±3.52 (3 
H, m, H3, H4 and H5), 3.64 (1 H, ddd, J6,6a = 11.5, J5,6 = 4.0 Hz, H6), 3.77 (1 H, ddd, J6,6a = 
11.5, J5,6a = 2.0 Hz, H6a), 3.86 (1 H, broad s, H2), 4.47 (1 H, dd, J6,OH = 6.0, J6a,OH 6.0 Hz, 6-
OH), 4.75 (1 H, d, J =  5.5 Hz, OH), 4.85 (1 H, d, J =  5.5 Hz, OH), 5.07 (1 H, d, J =  4.0 Hz, 
OH), 5.24 (1 H, d, J1,2 = 1.0 Hz, H1), 7.15 (2 H, app. d, Ar), 7.38 (2 H, app. d, Ar); 13C-NMR 
(125 MHz, d6-'062į.1 (1 C, Me), 61.4, 67.5, 72.0, 72.4, 75.7 (5C, C2,3,4,5,6), 89.7 (1 
C, C1), 130.1, 131.5, 132.6, 137.3 (6C, Ar); HRMS (ESI)+ m/z 287.0949 [C13H19O5S (M + H)+ 
requires 287.0948] 
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4-Methylphenyl 6-O-acetyl-1-thio-Į-D-mannopyranoside (23) 
The tetraol 22 (100 mg, 0.34 mmol) was suspended in EtOAc (10 mL), then conc. H2SO4 (2 
drops) were added and the mixture stirred for two days. The reaction was then poured into sat. 
NaHCO3 (20 mL), and the aqueous phase extracted with EtOAc (3 × 10 mL). The combined 
organic phase was dried over MgSO4, filtered and the solvent evaporated. The residue was 
purified by flash chromatography (EtOAc:MeOH:H2O, 17:2:1), giving 23 as a colourless oil 
that crystallized upon standing, m.p. 139-&>Į@D24 +221° (c 0.8, MeOH); 1H-NMR (500 
MHz, d6-'062į+V0H+V3K0H+P+DQG+
H, broad s, H2), 4.02 (1 H, m, H5), 4.05 (1 H, dd, J6,6a = 11.0, J5,6 = 7.5 Hz, H6), 4.27 (1 H, dd, 
J6,6a = 11.0, J5,6a = 1.0 Hz, H6a), 4.89 (1 H, d, JOH = 4.0 Hz, OH), 5.13 (1 H, d, JOH = 5.0 Hz, 
OH), 5.19 (1 H, broad s, OH), 5.23 (1 H, d, J1,2 = 1.5 Hz, H1), 7.15 (2 H, app. d, Ar), 7.35 (2 
H, app. d, Ar); 13C-NMR (125 MHz, d6-'062į&0H&3K0H
67.1, 71.3, 71.6, 71.8 (5 × 1C, C2,3,4,5,6), 88.7 (1 C, C1), 129.7, 130.3, 132.0, 137.1 (6C, Ar), 
170.2 (1 C, C=O); HRMS (ESI)+ m/z 351.0872 [C15H20O6SNa (M+Na)+ requires 351.0873]. 
4-Methylphenyl 2,4,6-tri-O-acetyl-1-thio-Į-D-mannopyranoside (23) 
The triol 23 (186 mg, 0.56 mmol) was dissolved in dry CH2Cl2 (4.5 mL). Triethyl orthoacetate 
(0.37 mL, 2.24 mmol) and p-toluenesulfonic acid monohydrate (14 mg, 0.074 mmol) were 
added. The reaction was left to stir for 30 min, when TLC analysis indicated complete 
consumption of the starting material. The reaction was stopped by the addition of TEA (100 
PL), diluted with CHCl3 (10 mL) and washed with water (2 × 20 mL) and brine (20 mL). The 
organic phase was dried (MgSO4), filtered and rotary evaporated. The residue was redissolved 
in dry CH2Cl2 (10.0 mL) and dry pyridine (3 mL). Acetic anhydride (1 mL) was then added, 
and the reaction stirred for 2 h. The reaction was then diluted with CH2Cl2 (10.0 mL) and 
washed with water (2 × 20 mL) and brine (20 mL). The organic phase was dried over MgSO4, 
filtered and concentrated. The remaining pyridine was removed by azeotropic distillation with 
toluene (2 × 30 mL), and the residue dissolved in CH2Cl2 (8.75 mL). A 1M solution of HCl 
was added (3.75 mL) and the biphasic solution vigorously stirred for 20 min. The acqueous 
phase was separated and the organic layer diluted with CH2Cl2 (15 mL) and washed with water 
(2 × 20 mL), sat. NaHCO3 (20 mL) and brine (20 mL). The crude was purified by flash 
chromatography (EtOAc:hexane, (1:9o6:4)), yielding 24 (203 mg, 87% over three steps) as a 
thick oil that crystallized upon standing. >Į@D22 +115° (c 0.1, CHCl3); 1H-NMR (400 MHz, 
CDCl3į+V0H × 3 H, s, Me), 2.24 (1 H, d, J3,OH = 8.4 Hz, OH), 2.33 (3 H, 
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s, PhMe), 4.07 (1 H, ddd, J3,4 = 9.9, J3,OH = 8.4, J2,3 = 3.4 Hz, H3), 4.13 (1 H, dd, J6,6a = 12.0, 
J5,6a = 2.0, H6a), 4.31 (1 H, dd, J6,6a =12.2, J5,6 = 5.9 Hz, H6), 4.51 (1 H, ddd, J3,4 = 9.9, J5,6 = 
5.8, J5,6a = 2.2 Hz, H5), 5.11 (1 H, t, J3,4 = J4,5 = 9.9 Hz, H4), 5.32 (1 H, dd, J2,3 = 3.5, J1,2 = 1.4 
Hz, H2), 5.49 (1 H, d, J1,2 = 1.4 Hz, H1), 7.12 (2 H, app. d, J = 8.3 Hz, Ar), 7.37 (2 H, d, J = 
8.2 Hz, Ar); 13C-NMR (101 MHz, CDCl3į × 1C, Me), 21.3 (1 C, PhMe), 
62.4, 68.8, 69.0, 69.4, 73.5 (5 × 1C, C2,3,4,5,6), 85.5 (1 C, C1), 127.8, 129.0, 132.6, 137.8 
(6C, PhMe), 170.3, 170.5, 170.6 (3 × 1C, C=O); HRMS (ESI)+ m/z 413.1265 [C19H25O8S 
(M+H)+ requires 413.1265]. 
 
 
 
4-Methylphenyl 3-O-(2,3,4,6-tetra-O-acetyl-Į-D-mannopyranoside)-2,4,6-tri-O-acetyl-1-
thio-Į-D-mannopyranoside (25) 
A solution of alcohol 24 (50 mg, 0.12 mmol) and trichloroacetimidate 21 (60 mg, 0.12 mmol) 
in dry CH2Cl2 (1.5 mL) was stirred with freshly activated 3 Å molecular sieves for 45 min. The 
mixture was cooled to -20 °C and triflic acid (1 PL, 0.01 mmol) was added. The mixture was 
stirred for 15 min at -20 °C, then temperature was raised to -10°C. After 5 min, the reaction 
was quenched with Et3N (0.1 mL), allowed to warm to room temperature, filtered and the 
solvent evaporated under reduced pressure. The crude residue was purified by flash 
chromatography (EtOAc:hexane (1:19o3:7)), yielding 25 (90 mg, 95%) as a colourless oil. 
>Į@D23 +76° (c 0.4, CHCl3); 1H-NMR (500 MHz, CDCl3į06, 2.15, 2.15, 2.18, 
2.20 (7 × 3 H, s, Me), 2.33 (3 H, s, PhMe), 4.12±4.06 (3 H, m, H6a, H5' and H6a'), 4.16 (1 H, 
dd, J3,4 = 9.8, J2,3 = 3.4 Hz, H3), 4.23 (1 H, dd, J6',6a' = 12.5, J5',6' = 6.3 Hz, H6'), 4.27 (1 H, dd, 
J6,6a = 12.5, J5,6 = 6.3 Hz, H6), 4.46 (ddd, J3,4 = 9.7, J5,6 = 6.3, J5,6a = 2.4 Hz, H5), 5.03 (1 H, s, 
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H1' and H2'), 5.22 (1 H, dd, J3',4' = 10.3, J2',3' = 2.9 Hz, H3'), 5.25 (1 H, app. t, J3',4' = J4',5' = 10.3 
Hz, H4'), 5.34 (1 H, dd, J3,4 = J4,5 = 9.8 Hz, H4), 5.44 (1 H, d, J1,2 = 1.2 Hz, H1), 5.49 (1 H, dd, 
J2,3 = 3.4, J1,2 = 1.5 Hz, H2), 7.12 (2 H, app. d, J = 7.9, Ar),7.34 (2 H, app. d, J = 7.9, Ar); 13C-
NMR (125 MHz, CDCl3į20.77, 20.78, 20.8, 20.9, 20.97, 20.99, 21.05 (7 × 1C, Me), 21.3 (1 
C, PhMe), 62.7, 62.8 (2 C, C6 and C6'), 66.1 (1 C, C4'), 68.2 (1 C, C4), 68.3 (1 C, C3'), 69.67 
(1 C, C5'), 69.71 (1 C, C5), 70.1 (1 C, C2'), 72.4 (1 C, C2), 75.1 (1 C, C3), 86.2 (1 C, C1), 99.0 
(1 C, C1'), 128.8, 130.1, 132.7, 138.7 (6C, Ar), 169.7, 169.97, 170.00, 170.2, 170.4, 170.7, 
170.9 (7 × 1C, C=O); HRMS (ESI)+ m/z 743.2220 [C33H43O17S (M+H)+ requires 743.2215]. 
 
2,3,4,6-Tetra-O-acetyl-Į-D-mannopyranosyl-(1,3)-2,4,6-tri-O-acetyl-Įȕ-D-
mannopyranose (26) 
Thioglycoside 25 (60 mg, 0.08 mmol) was dissolved in acetone (3 mL), and the solution cooled 
to -10°C. Crystalline NBS (34 mg, 0.19 mmol) was added and the reaction stirred for 30 min. 
Water (50 PL) was added and the reaction stirred for an additional 30 min. TLC analysis shown 
completion of the reaction, and the mixture quenched with solid NH4Cl (20 mg, 0.37 mmol) 
and stirred for 10 min. The reaction was diluted with EtOAc (15 mL) and the acetone removed 
under reduced pressure. The solution was washed with brine (2 × 20 mL), and the combined 
aqueous layers extracted with EtOAc (2 × 20 mL). The combined organic phase was dried over 
anhydrous MgSO4, filtered and concentrated. Flash chromatography (EtOAc:hexane, 
(2:3o1:1)) afforded the hemiacetal 26 (0.305 g, 65%) as a colourless oil. 1H-NMR for the Į-
anomer (400 MHz, CDCl3į±2.21 (7 × 3 H, s, Ac), 3.25 (1 H, d, J1,OH = 4.0 Hz, OH), 
4.05±4.29 (7 H, m, H3',5,6a,6,5',6',6a'), 5.00 (1 H, d, J1',2' = 1.5 Hz, H1'), 5.02 (1 H, d, J2',3' = 
3.0, J1',2' = 2.0 Hz, H2'), 5.22 (1 H, t, J2,3 = 3.0 Hz, H3), 5.25 (1 H, dd, J1,OH = 3.0, J1,2 = 2.0 Hz, 
H1), 5.27 (1 H, dd, J2,3 = 3.0, J1,2 = 2.0 Hz, H2), 5.29, 5.32 (2 H, m, H4 and H4'); 13C-NMR 
for the Į-anomer (125 MHz, CDCl3į±21.0 (7 C, Me), 62.5, 62.7 (2 C, C6,6'), 66.0, 67.9, 
68.3, 68.5, 69.3, 70.0, 71.5, 74.2 (8 C, C2,3,4,5,C2',3',4',5'), 92.1 (1 C, C1), 98.8 (1 C, C1'), 
169.7, 169.97, 170.01, 170.1, 170.6, 170.9, 171.0 (7 C, C=O); HRMS (ESI)+ m/z 659.1793 
[C26H36O18Na (M+Na)+ requires 659.1794]. 
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2,3,4,6-Tetra-O-acetyl-Į-D-mannopyranosyl-(1,3)-2,4,6-tri-O-acetyl-Į-D-
mannopyranosyl trichloroacetimidate (27)  
DBU (0.600 µL, 3.94 µmol) was added to a mixture of the hemiacetal 26 (0.126 g, 0.197 mmol) 
and trichloroacetonitrile (90.0 µL, 0.887 mmol) in dichloromethane (2 mL) at 0 ºC under N2. 
The mixture was warmed to r.t. and stirred for 3 h and then concentrated under reduced pressure 
to give a light yellow residue, which was purified by flash chromatography 
(EtOAc:hexane:Et3N, (2:3:0.1o1:1:0.1)) to afford the trichloroacetimidate 27 (0.115 g, 75%) 
as a colourless oil. 1H-NMR (400 MHz, CDCl3į±2.22 (7 × 3 H, s, Ac), 3.99±4.25 (7 H, 
m, H6,6a,3',5',6',6a'), 5.00 (2 H, m, H1',2'), 5.18 (1 H, dd, J3',4' = 10, J2',3' = 3.5 Hz, H3'), 5.26 
(1 H, app. t, J3',4' = J4',5' = 10 Hz, H4'), 5.37 (1 H, t, J3,4 = J4,5 = 10 Hz, H4), 5.38 (1 H, m, H2), 
6.27 (1 H, d, J1,2 = 1.0 Hz, H1), 8.80 (1 H, s, NH); 13C-NMR (125 MHz, CDCl3į±20.9 
(7 C, Me), 62.18, 62.23 (2 C, C6,C6'), 65.7, 67.0, 68.2, 69.4, 69.6, 69.9, 71.4, 74.7 (8 C, 
C2,3,4,5,2',3',4',5'), 90.6 (1 C, CCl3), 94.4 (1 C, C1'), 99.2 (1 C, C1), 159.6 (1 C, C=NH), 169.7, 
169.8, 170.1, 171.1, 170.62, 170.65 (7 C, C=O). 
 
 
 
Methyl 2,3,4,6-tetra-O-acetyl-Į-D-mannopyranosyl-(1,3)-2,4,6-tri-O-acetyl-Į-D-
mannopyranosyl-(1,2)-3,4,6-tri-O-benzyl-Į-D-mannopyranosyl-(1,2)-3,4,6-tri-O-benzyl-
Į-D-mannopyranoside (28) 
A solution of TfOH in toluene (1% v/v, 65 µL, 0.0074 mmol) was added to a mixture of the 
trichloroacetimidate 27 (58.0 mg, 0.074 mmol), alcohol 19 (51.0 mg, 0.057 mmol) and freshly 
DFWLYDWHGcPROHFXODUVLHYHVLQGU\WROXHQHP/DWÛ&XQGHU12. The mixture was stirred 
for 3 h, then was quenched with Et3N (0.1 mL), filtered through Celite, washed with 
dichloromethane and concentrated. The residue was purified by flash chromatography 
(EtOAc:hexane, (1:9o1:4)) to afford the fully protected tetrasaccharide 28 (68.8 mg, 85%) as 
DFRORXUOHVVRLO>Į@D22 +24° (c 0.1, CHCl3); 1H-NMR (400 MHz, CDCl3į
2.05, 2.06, 2.13, 2.21 (7 × 3 H, s, Ac), 3.22 (3 H, s, OMe), 3.68±4.06 (17 H, m), 4.18 (1 H, dd, 
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J =  3.6, 10 Hz), 4.27 (1 H, dd, J =  12.5, 4.0 Hz), 4.48±4.69 (10 H, m), 4.78 (1 H, d, J1,2 = 1.2 
Hz, H1), 4.80±4.84 (2 H, m), 4.91 (1 H, d, J1,2 = 1.2 Hz, H1), 4.99 (1 H, d, J1,2 = 1.6 Hz, H1), 
5.05 (1 H, dd, J2,3 = 3.2, J1,2 = 1.6 Hz, H2), 5.22 (1 H, d, J1,2 = 2.0 Hz, H1), 5.20-5.34 (4 H, m), 
7.20±7.36 (30 H, m, Ar); 13C-NMR (125 MHz, CDCl3į8±21.2 (7 C, Me), 54.8 (1 C, OMe), 
68.6±77.4 (26 C, C2,3,4,5,6,2',3',4',5',6',2'',3'',4'',5'',6'',2''',3'''',4''',5''',6''',PhCH2), 99.1 (1 C, 
C1''), 99.2, 99.8, 100.5 (3 × 1C, C1,1',1'''), 127.6±138.6 (30 C, Ar), 169.8±170.8 (7 C, C=O); 
HRMS (ESI)+ m/z 1537.5830 [C81H94O28Na (M+Na)+ requires 1537.5824]. 
 
0HWK\OĮ-D-mannopyranosyl-(1,3)-Į-D-mannopyranosyl-(1,2)-Į-D-mannopyranosyl-
(1,2)-Į-D-mannopyranoside ((Man)4OMe) 
Sodium methoxide in methanol (1 M, 12.0 µL, 0.011 mmol) was added to a solution of the 
tetrasaccharide 28 (43.0 mg, 0.028 mmol) in MeOH/CH2Cl2 (3:1, 4 mL) and the mixture was 
stirred for 2 h. After neutralization with Dowex-50 resin (H+ form), the mixture was filtered 
and concentrated. The crude residue was dissolved in a mixture of EtOAc/MeOH/H2O (15:2:2, 
17 mL) and aq 0.5 M HCl (0.1 mL), 20% Pd(OH)2/C (20 mg) was added, and the mixture was 
stirred under an atmosphere of hydrogen for 18 h. The reaction mixture was filtered through a 
layer of Celite, and washed thoroughly with MeOH:H2O (2:1), and concentrated under reduced 
pressure. The residue was purified by flash chromatography (EtOAc:MeOH:H2O (4:2:1)), and 
then by C18 reversed phase chromatography (CH3CN:H2O, 95:5), to afford the tetrasaccharide 
(Man)4OMe (17.7 mg, 90%) as a colourless oil. 1H-NMR (500 MHz, D22į+V
OMe), 3.42±3.95 (20 H, m, H3,4,5,6a,6b,3',4',5',6a',6b', 3'',4'',5'',6a'',6b'', 3''',4''',5''',6a''',6b'''), 
3.97 (1 H, dd, J2,3 = 5.5, J1,2 = 3.0 Hz, H2'), 4.08 (1 H, dd, J2,3 = 5.5, J1,2 = 3.0 Hz, H2'''), 4.12 
(1 H, dd, J2,3 = 5.5, J1,2 = 3.0 Hz, H2''), 4.24 (1 H, dd, J2,3 = 5.5, J1,2 = 3.0 Hz, H2), 5.00 (1 H, 
d, J1,2 = 1.5 Hz, H1''), 5.05 (1 H, d, J1,2 = 1.5 Hz, H1), 5.16 (1 H, d, J1,2 = 1.5 Hz, H1'''), 5.00 
(1 H, d, J1,2 = 1.5 Hz, H1''); 13C-NMR (125 MHz, D22į8 (1 C, OMe), 60.8, 60.9, 61.0, 
61.1, 66.2, 66.8, 67.0, 69.50, 69.54, 69.9, 70.0, 70.2, 72.5, 73.2, 77.8, 78.4, 78.6, 78.7 (20 C, 
C2,3,4,5,6,2',3',4',5',6',2'',3'',4'',5'',6'',2''',3'''',4''',5''',6'''), 99.2 (1 C, C1''), 100.6 (1 C, C1'), 102.1 
(1 C, C1'''), 102.2 (1 C, C1); HRMS (ESI)+ m/z 703.2264 [C25H44O21Na (M + Na)+ requires 
703.2267]. 
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Labelled tetramannosides (Man)4OMe were synthesized accordingly to the above described 
procedure starting from individually isotope-labelled 1-13C-, 1-13C,1-2H-, 2-13C-, 2-13C,2-18O- 
and 1,2-13C2-D-mannoses (Omicron Biochemicals, USA). 
 
(Man)4OMe 
isotopologue 
Label (%) Characteristic NMR shifts (500 MHz, D2O) 
[1-13C] 1-13C: 99 1H NMR: 4.92 (1 H, dd, JC,H = 143.2, J1,2 = 1.5 
Hz, H1). 
13C NMR: 102.05 (1 C, C1). 
[1-13C, 1-2H] 1-13C: 99 
1-2H: 99 
1H NMR: H1 is 2H, no signal. 
13C NMR: 102.0 (1 C, C1) 
[2-13C] 2-13C: 99 1H NMR: 4.08 (1 H, m, JC,H = 151.1 Hz, H2) 
13C NMR: 69.49 (1 C, C2). 
[2-13C, 2-18O] 2-13C: 99 
2-18O: 90 
1H NMR: 4.08 (1 H, m, JC,H = 151.1 Hz, H2) 
13C NMR: 69.50 (1 C, C2). 
[1,2-13C2] 1-13C: 99 
2-13C: 99 
1H NMR: 4.08 (1 H, m, JC,H = 151.1 Hz, H2), 4.92 
(1 H, dd, JC,H = 143.2, J1,2 = 1.5 Hz, H1). 
13C NMR: 69.49 (1 C, d, J1,2 = 46.9 Hz, C2), 
102.05 (1 C, d, J1,2 = 46.9 Hz, C1). 
 
References 
 
(1) Winter, G., xia2: an expert system for macromolecular crystallography data reduction, J. Appl. 
Crystallogr. 2010, 43, 186-190. 
(2) Evans, P. R.; Murshudov, G. N., How good are my data and what is the resolution?, Acta 
Crystallogr. Sect. D 2013, 69, 1204-1214. 
(3) Murshudov, G. N.; Skubak, P.; Lebedev, A. A.; Pannu, N. S.; Steiner, R. A.; Nicholls, R. A.; 
Winn, M. D.; Long, F.; Vagin, A. A., REFMAC5 for the refinement of macromolecular crystal 
structures, Acta Crystallogr. D 2011, 67, 355-367. 
(4) Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K., Features and development of Coot, Acta 
Crystallogr. Sect. D 2010, 66, 486-501. 
(5) Cremer, D.; Pople, J. A., General definition of ring puckering coordinates, J. Am. Chem. Soc. 
1975, 97, 1354-1358. 
(6) Agirre, J.; Iglesias-Fernandez, J.; Rovira, C.; Davies, G. J.; Wilson, K. S.; Cowtan, K. D., 
Privateer: software for the conformational validation of carbohydrate structures, Nat. Struct. Mol. 
Biol. 2015, 22, 833-4. 
 81 
 
(7) McNicholas, S.; Potterton, E.; Wilson, K. S.; Noble, M. E. M., Presenting your structures: the 
CCP4mg molecular-graphics software, Acta Crystallogr. D 2011, 67, 386-394. 
(8) Ciucanu, I.; Kerek, F., A simple and rapid method for the permethylation of carbohydrates, 
Carbohydr. Res. 1984, 131, 209-217. 
(9) Petricevic, M.; Sobala, L. F.; Fernandes, P.; Raich, L.; Thompson, A. J.; Bernardo-Seisdedos, G.; 
Millet, O.; Zhu, S.; Sollogoub, M.; Jimenez-Barbero, J.; Rovira, C.; Davies, G. J.; Williams, S. J., 
Contribution of shape and charge to the inhibition of a family GH99 endo-Į-1,2-mannanase, J. Am. 
Chem. Soc. 2017, 139, 1089±1097. 
(10) Case, D. A.; Darden, T. A.; Cheatham, T. E.; Simmerling, J. W. C.; Duke, R.; Luo, R.; Crowley, 
M. F.; Walker, R.; Zhang, W.; Merz, K. M.; Wang, B.; Hayik, S.; Roitberg, A. E.; Seabra, G.; 
Kolossváry, I.; Wong, K. F.; Paesani, F.; Vanicek, J.; Wu, X.; Brozell, S.; Steinbrecher, T.; Gohlke, 
H.; Yang, L.; Tan, C.; Mongan, J.; Hornak, V.; Cui, G.; Mathews, D. H.; Seetin, M. G.; Sagui, C.; 
Babin, V.; Kollman, P. AMBER 11, University of California, San Francisco: 2010. 
(11) Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A.; Simmerling, C., Comparison of 
multiple Amber force fields and development of improved protein backbone parameters, Proteins: 
Struct., Funct., Bioinf. 2006, 65, 712-725. 
(12) Kirschner, K. N.; Yongye, A. B.; Tschampel, S. M.; González-Outeiriño, J.; Daniels, C. R.; 
Foley, B. L.; Woods, R. J., GLYCAM06: A generalizable biomolecular force field. Carbohydrates, J. 
Comput. Chem. 2008, 29, 622-655. 
(13) Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L., Comparison of 
simple potential functions for simulating liquid water, J. Chem. Phys. 1983, 79, 926-935. 
(14) Humphrey, W.; Dalke, A.; Schulten, K., VMD: Visual molecular dynamics, J. Mol. Graph. 1996, 
14, 33-38. 
(15) Laio, A.; VandeVondele, J.; Rothlisberger, U., A Hamiltonian electrostatic coupling scheme for 
hybrid Car±Parrinello molecular dynamics simulations, J. Chem. Phys. 2002, 116, 6941-6947. 
(16) Car, R.; Parrinello, M., Unified Approach for Molecular Dynamics and Density-Functional 
Theory, Phys. Rev. Lett. 1985, 55, 2471-2474. 
(17) Troullier, N.; Martins, J. L., Efficient pseudopotentials for plane-wave calculations, Phys. Rev. B 
1991, 43, 1993-2006. 
(18) Perdew, J. P.; Burke, K.; Ernzerhof, M., Generalized Gradient Approximation Made Simple, 
Phys. Rev. Lett. 1996, 77, 3865-3868. 
(19) Ireta, J.; Neugebauer, J.; Scheffler, M., On the Accuracy of DFT for Describing Hydrogen 
%RQGV(?'HSHQGHQFHRQWKH%RQG'LUHFWLRQDOLW\ J. Phys. Chem. A 2004, 108, 5692-5698. 
(20) Marianski, M.; Supady, A.; Ingram, T.; Schneider, M.; Baldauf, C., Assessing the Accuracy of 
Across-the-Scale Methods for Predicting Carbohydrate Conformational Energies for the Examples of 
*OXFRVHDQGĮ-Maltose, J. Chem. Theory Comput. 2016, 12, 6157-6168. 
(21) Ardèvol, A.; Rovira, C., Reaction Mechanisms in Carbohydrate-Active Enzymes: Glycoside 
Hydrolases and Glycosyltransferases. Insights from ab Initio Quantum Mechanics/Molecular 
Mechanics Dynamic Simulations, J. Am. Chem. Soc. 2015, 137, 7528-7547. 
(22) Laio, A.; Parrinello, M., Escaping free-energy minima, Proc. Natl. Acad. Sci. USA 2002, 99, 
12562-12566. 
 82 
 
(23) Tribello, G. A.; Bonomi, M.; Branduardi, D.; Camilloni, C.; Bussi, G., PLUMED 2: New 
feathers for an old bird, Comput. Phys. Commun. 2014, 185, 604-613. 
(24) Chan, J.; Lewis, A. R.; Gilbert, M.; Karwaski, M. F.; Bennet, A. J., A direct NMR method for the 
measurement of competitive kinetic isotope effects, Nat. Chem. Biol. 2010, 6, 405-7. 
(25) Claridge, T. D. W., High-resolution NMR techniques in organic chemistry. Elsevier: 2009. 
(26) Pauli, G. F.; Jaki, B. U.; Lankin, D. C., Quantitative 1+105(?'HYHORSPHQWDQG3RWHQWLDORID
Method for Natural Products Analysis, J. Nat. Prod. 2005, 68, 133-149. 
(27) Melander, L. C. S.; Saunders, W. H., Reaction rates of isotopic molecules. Wiley: 1980. 
(28) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J., Safe and 
Convenient Procedure for Solvent Purification, Organometallics 1996, 15, 1518-1520. 
(29) Still, W. C.; Kahn, M.; Mitra, A. M., Rapid Chromatographic Technique for Preparative 
Separations with Moderate Resolution, J. Org. Chem. 1978, 43, 2923-2925. 
(30) Lu, D.; Zhu, S.; Sobala, L. F.; Bernardo-Seisdedos, G.; Millet, O.; Zhang, Y.; Jiménez-Barbero, 
J.; Davies, G. J.; Sollogoub, M., From 1,4-Disaccharide to 1,3-Glycosyl Carbasugar: Synthesis of a 
Bespoke Inhibitor of Family GH99 Endo-Į-mannosidase, Org. Lett. 2018, 20, 7488-7492. 
(31) Floyd, N.; Vijayakrishnan, B.; Koeppe, J. R.; Davis, B. G., Thiyl Glycosylation of Olefinic 
PURWHLQV6ဨ/LQNHG*O\FRFRQMXJDWH6\QWKHVLVAngew. Chem. Int. Ed. 2009, 48, 7798-7802. 
(32) Beignet, J.; Tiernan, J.; Woo, C. H.; Kariuki, B. M.; Cox, L. R., Stereoselective Synthesis of 
Allyl-C-PDQQRV\O&RPSRXQGV(?8VHRID7HPSRUDU\6LOLFRQ&RQQHFWLRQLQ Intramolecular Allylation 
Strategies with Allylsilanes, J. Org. Chem. 2004, 69, 6341-6356. 
(33) Ito, Y.; Hagihara, S.; Arai, M. A.; Matsuo, I.; Takatani, M., Synthesis of fluorine substituted 
oligosaccharide analogues of monoglucosylated glycan chain, a proposed ligand of lectin-chaperone 
calreticulin and calnexin, Glycoconj. J. 2004, 21, 257-66. 
:DWW-$:LOOLDPV6-5DSLGLWHUDWLYHDVVHPEO\RIRFW\OĮ-1,6-oligomannosides and their 6-
deoxy equivalents, Org. Biomol. Chem. 2005, 3, 1982-1992. 
 
 83 
 
1H NMR (600 MHz) spectrum of 5 
 
13C NMR (151 MHz) spectrum of 5 
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13C DEPT135 spectrum of 5 
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1H NMR spectrum of compound 7 (400 MHz, D2O)  
 
13C NMR spectrum of compound 7 (100.6 MHz, D2O)  
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1H NMR spectrum of compound 3 (400 MHz, D2O)  
 
13C NMR spectrum of compound 3 (100.6 MHz, D2O)
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1H NMR spectrum of compound 1 (400 MHz, CD3OD)  
 
13C NMR spectrum of compound 1 (100.6 MHz, CD3OD)  
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1H NMR spectrum of compound 11 (400 MHz, CDCl3)  
 
13C NMR spectrum of compound 11 (100.6 MHz, CDCl3)  
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1H NMR spectrum of compound 2 (400 MHz, D2O)  
 
13C NMR spectrum of compound 2 (100.6 MHz, D2O) 
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